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Cornell University 2017 
 
The small GTPase Cdc42 is an essential signaling molecule in multiple cellular 
processes, including proliferation, migration, division and apoptosis.  The overexpression of 
Cdc42 is found in certain breast carcinomas, bringing to question its roles in normal mammary 
cell function and during breast cancer progression.  In this thesis, I have examined the roles of 
Cdc42 during mammary gland development, and then analyzed the effects of overactive Cdc42 
signaling on mammary epithelial cells (MECs).  To accomplish this, I used an in vivo mouse 
model as well as primary cell culture systems.   
In the initial study, the conditional-knockout of Cdc42 in the epithelia of adult mouse 
mammary glands resulted in the altered cellular localization of Par complex members, as well as 
E-cadherin.  These changes accompanied a disorganization of the epithelial cells within the 
mammary gland, and led to insufficient lactation.  This loss-of-function mouse model showed 
that Cdc42 is essential for the proper maintenance of both apical-basal cell polarity and E-
cadherin-based cell-cell junctions in the adult mammary gland.  These results raised further 
interest concerning the roles Cdc42 may have in breast carcinoma development, in which proper 
apical-basal cell polarity and cell-cell communication are commonly lost.   
I next examined the effects of aberrant Cdc42 signaling in primary MECs by utilizing the 
constitutively-active Cdc42[F28L] mutant.  In a monolayer culture system, Cdc42[F28L] 
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stimulated the formation of actin-based stress fibers, and gave rise to multi-nucleated cells, while 
in a three-dimensional model system it drove the primary MECs toward an invasive phenotype in 
an IQGAP1-dependent manner.  The primary MECs expressing Cdc42[F28L] lost the proper 
localization of E-cadherin at cell-cell contacts and no longer formed normal, hollowed alveolar 
lumens, but instead began to abnormally fill the luminal space and invade out into the 
surrounding environment.   
A common phenotype exhibited by these model systems was the proper maintenance of 
E-cadherin-based cell-cell contacts between mammary epithelial cells.  Interestingly, both the 
deletion of Cdc42 and its constitutive activation resulted in abnormal E-cadherin expression and 
localization within mammary epithelial cells.  IQGAP1 is likely the primary Cdc42 effector 
responsible for these phenotypes, as it can both regulate E-cadherin stability at cell-cell junctions 
as well as bundle microtubules at the leading edge of invasive cells.  These studies suggest 
IQGAP1 is a critical signaling effector of Cdc42 in adult mammary epithelial cells and that, 
when not properly regulated, it can shift the epithelia toward an invasive phenotype.   
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Chapter 1 
 
Introduction 
 
Small molecular-weight guanosine triphosphatases (GTPases) transduce a diverse array of 
cellular signals that affect cell division, migration, differentiation, and apoptosis (1–3).  Cdc42 (for 
Cell Division Cycle 42) is a member of the Rho subgroup within the Ras superfamily of GTPases, 
and was first discovered as an essential gene in Saccharomyces cerevisiae, where it functions at 
actin-dependent, polarized budding sites of the plasma membrane to allow the establishment of 
cell polarity and division (4).  In the absence of Cdc42, yeast cells were shown to grow larger yet 
remain unbudded (5).  At roughly the same time, the human homolog, initially named Cdc42Hs, 
was discovered when searching for novel signaling partners for the epidermal growth factor 
receptor (EGFR) (6).  Further studies extended our understanding of the actions of Cdc42 in 
mammalian cell function, where it was shown to play essential roles not only in the polarization 
of epithelial cells, but also in their migration, intracellular trafficking, differentiation, metabolism 
and division (7–11).   Considering the wide array of mammalian cellular functions now associated 
with Cdc42, some of which are found to be deregulated in disease states (12–14), a key question 
arises in understanding how higher-evolved cells orchestrate Cdc42 signaling to perform their 
various tasks in functional tissues.  This question is relevant to the study of tumorigenesis, 
particularly when considering that Cdc42 is found to be overexpressed in human invasive breast 
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ductal carcinoma (12), and that the expression of a hyper-active mutant of Cdc42 causes NIH3T3 
fibroblasts to attain hallmark characteristics of cancer (15). 
Cdc42 signaling is tightly regulated in cells  
The expression of Cdc42 is important for dictating appropriate cell signaling, but the mere 
presence or absence of the translated Cdc42 protein is not the only means by which downstream 
signaling is controlled.  One level of control over Cdc42 signaling is through a binary switch-like 
mechanism that turns the downstream signaling “on” or “off”.  This switch-mechanism of activity 
provides a secondary level of control over the activation of downstream signals via the nucleotide 
binding status of Cdc42.  When Cdc42 binds to guanosine triphosphate (GTP), it is considered 
“active” and has enhanced binding potential to downstream effector molecules.  Cdc42’s intrinsic 
GTPase enzymatic activity will eventually hydrolyze the GTP into guanosine diphosphate (GDP), 
which returns Cdc42 to an “inactive” state that no longer favors effector-binding.  While the 
intrinsic rate of GTPase activity of Cdc42 is quite low, it can be greatly accelerated by the binding 
to Cdc42 of a GTPase activating protein (GAP) (16).  When a GAP binds to GTP-bound Cdc42, 
a structural shift occurs that allows the hydrolytic cleavage of a phosphate group from the GTP, 
and the resultant GDP that occupies the nucleotide binding pocket lowers the potential for binding 
downstream effector molecules.  However, when a guanine nucleotide exchange factor (GEF) 
binds to GDP-bound Cdc42, it destabilizes the binding of nucleotide to Cdc42, resulting in 
dissociation.  This nucleotide-free Cdc42 is then likely to bind to GTP (which is, on average, at a 
ten-fold higher concentration than GDP in the cytoplasm of the cell), thereby activating 
downstream signaling (17).  GAP proteins can therefore be thought of as negative regulators of 
downstream Cdc42 signaling, and GEF proteins as positive regulators.  These classes of molecules 
that affect the activity of Cdc42 become extremely relevant to cancer biology, as a hyperactive, 
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truncated mutant of a Cdc42 GEF is found in diffuse b-cell lymphoma (18), while a Cdc42 GAP 
is poorly expressed in certain liver cancers (19).  In each of these cases, the control over Cdc42 
activity and its downstream signaling is altered in cancer cells.   
Another class of Cdc42-regulatory proteins has emerged from studies of Rho GTPases, and 
they are referred to as guanosine nucleotide dissociation inhibitors, or GDIs.  GDIs have the ability 
to facilitate the dissociation of Cdc42 from the plasma membrane, and can also inhibit GDP 
exchange as well as GTP hydrolysis (20).  This allows GDIs to have a unique level of control over 
not only the nucleotide binding state of Cdc42, but also its localization in the cell. Together, these 
GEFs, GAPs and GDIs provide a mechanism for cells to orchestrate Cdc42 signaling and 
localization with high fidelity, allowing the expressed Cdc42 protein to be used in multiple cellular 
processes (Figure 1.1). 
Cdc42 modulates the cell cytoskeleton through a variety of effectors. 
The stimulation of G-protein-coupled receptors, receptor tyrosine kinases and integrins can 
all lead to the activation of GEFs for Cdc42 (21).  Then, once Cdc42 is GTP-bound, a wide array 
of downstream binding partners, or effectors, can be activated.  While Cdc42 was initially shown 
to be essential for the regulation of budding site selection in yeast (4) , thereby allowing polarized 
cell growth, it was later found that Cdc42 is also a regulator of the mammalian cell cytoskeleton 
through its potential binding to several effector molecules, including the Wiskott-Aldrich 
Syndrome protein (WASP), the mammalian Diaphanous-related (mDia) formin, the scaffold 
protein IQ-Motif Containing GTPase Activating Protein 1 (IQGAP1), and the p21-Activated 
Kinases (PAKs).  Given the accumulating evidence highlighting the critical impact of the 
cytoskeleton on various cell functions and survival, the ability of Cdc42 to have multiple 
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Figure 1.1.  The regulation of Cdc42 signaling to downstream effectors and its cellular effects.  
GTP-bound Cdc42 can act through a variety of effectors to affect multiple cellular processes, 
including cytoskeletal dynamics, differentiation and mitosis.  The tight regulation of Cdc42 
signaling activity is attained through the actions of guanine nucleotide exchange factors (GEFs), 
GTPase-activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs).  When 
bound to Cdc42, GEFs induce the release of GDP, allowing subsequent binding of GTP, thus 
activating downstream signaling.  When bound to Cdc42, GAPs induce GTP hydrolysis, thereby 
ceasing downstream signaling.  GDI-binding to Cdc42 causes dissociation from the membrane, 
and can inhibit GDP exchange as well as GTP-hydrolysis.   
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Figure 1.1 
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inputs into cytoskeletal dynamics contributes to the multiple roles played by this small GTPase in 
both normal development and disease.   
In studies that further examined mechanistically how Cdc42 is able to modulate the cell 
cytoskeleton, it was found that by binding to WASP, activated Cdc42 released an auto-inhibitory  
structural fold of WASP, thereby allowing it to interact with the Actin-Related Protein 2/3 (Arp 
2/3) complex to initiate actin assembly into branched filaments of the cytoskeleton (22, 23).  GTP-
bound Cdc42 was also shown to bind to mDia, releasing an auto-inhibitory conformation in the 
formin and inducing its actin filament assembly activity, such as the linear actin filaments found 
in filopodia and stress fibers within the cell (24).  Upon binding to the N-terminal regulatory 
domain of PAK family members, activated Cdc42 again releases an auto-inhibitory structural fold 
in these effectors, which then allows PAK to phosphorylate and inhibit Myosin Light Chain Kinase 
(MLCK) at the cell membrane, resulting in the promotion of lamellipodia formation (25, 26).  In 
a highly-esteemed and critical study from Alan Hall’s laboratory, the microinjection of the 
constitutively-active Cdc42(V12) mutant into Swiss 3T3 cells results in the formation of 
filamentous actin-rich filopodial extensions along the cell periphery, highlighting the potential of 
GTP-bound Cdc42 to drastically affect actin cytoskeletal dynamics (27).   
IQGAP1, although not a small GTPase GAP as its name suggests, does act as an effector 
of Cdc42 and interestingly, when GTP-bound Cdc42 binds to IQGAP1, this interaction inhibits 
the hydrolysis of GTP (28), thereby leading to larger pools of activated Cdc42 (29).  IQGAP1 is a 
scaffolding protein with binding sites for actin and it has been shown to crosslink actin filaments, 
thereby potentiating the formation of filopodia (30, 31).  The expression of IQGAP1 in mammalian 
cells has been shown to increase the cellular levels of GTP-bound Cdc42 and produce actin-rich 
microspikes at the plasma membrane (29).  It has also been shown that, when not bound to Cdc42, 
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IQGAP1 can bind directly to E-Cadherin and β-catenin and that this binding weakens the 
interaction of the actin cytoskeleton to adherens junctions between cells, resulting in increased 
degradation of E-Cadherin and therefore weakened cell-cell contacts (32, 33).  This dual-effect of 
IQGAP1 can be seen as a critical component of the transition of static, organized epithelial cells 
into a migratory phenotype.   
Taken together, these data place Cdc42 as a master regulator of actin-cytoskeletal 
dynamics, upon which a substantial amount of cellular processes rely.  Cdc42-signaling has also 
been shown to directly affect a range of cellular processes other than cytoskeletal modulation, 
including cell adhesion (34, 35), migration (36), apoptosis (37–39), cell-cycle progression (40–42) 
and polarity establishment (43–46).  Collectively, these studies of Cdc42 function in cell culture 
models have provided enormous insight into the myriad of cell signals that are affected by this 
GTPase, and have laid the framework for further investigating its roles in-vivo.                                                                             
Roles of Cdc42 in vivo           
Cdc42 has been shown to be an essential gene for higher eukaryotic life (2, 47), which 
relies on cells that must coordinate with one another to form functional tissues.  In C. elegans, 
Cdc42 is essential for the maintenance of the cellular asymmetry that allows proper mitotic spindle 
orientation and mitosis (48).  During Drosophila melanogaster development, Cdc42 plays a role 
in the establishment of apical and basolateral cell polarity (49), a critical step which allows the 
organization of cells during morphogenesis, and affects epithelial cell cohesion during tissue 
formation.  As studies moved into mammals, it was shown that the complete deletion of Cdc42 in 
the mouse (Mus Musculus) resulted in disorganized cells and a lack of primary ectoderm formation 
which caused lethality at embryonic day 6.5 (50).  Considering the multiple signaling networks 
that can be affected by Cdc42, it is logical that its expression is absolutely essential for mammalian 
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embryogenesis.  This embryonic-lethal phenotype prompted researchers to employ conditional 
knockout strategies to study Cdc42 in the mouse.  Use of the Cre/loxp system has provided this 
opportunity to study the roles of Cdc42 in selected mouse tissues of interest, and furthered our 
understanding of Cdc42 signaling by illustrating a physiological perspective to the roles of this 
small GTPase.  
In the heart, the loss of Cdc42 expression resulted in hypertrophic cardiac cell growth (51).  
Given the prior studies showing that Cdc42 can promote growth signaling in cells (52, 53), it was 
surprising to see that the loss of its expression resulted in hypertrophic cell growth.  This study 
showed that, in the heart, Cdc42 signaling activates c-Jun N-terminal kinase (JNK), which 
provides a protective and anti-hypertrophic signal in cardiomyocytes which have calcineurin-
NFAT activity induced by stress (51).  However, this was not the only unexpected phenotype 
accompanying the conditional deletion of Cdc42 in mouse tissues.  In neural progenitor cells, 
Cdc42 was found to be responsible for the establishment of apical-basal polarity, but it did not 
affect the normal progression of the cell cycle.  Interestingly, the conditional deletion of Cdc42 in 
this model resulted in an abnormally high number of basal progenitor cells within the tissue, due 
to an inability of the cells to migrate appropriately based on proper cell polarity (54).  Pancreatic 
development in the mouse was also shown to rely on Cdc42 signaling, again via the proper 
establishment of cell polarity during the morphogenesis of this tubulous organ.  Loss of Cdc42 
expression during the formation of the pancreas resulted in an abnormal organization of the cells 
within the organ, and a consequent alteration of the differentiation status of the cells (55).  Deletion 
of Cdc42 in skin keratinocytes of the mouse also resulted in a change of cell fate, and in the skin 
this was shown to be caused by alterations in β-catenin regulation (56).  Aberrant deposition of 
basement membrane components was also found at the dermal-epidermal junction of these mice 
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(57), suggesting that Cdc42 also contributes to the maintenance of the extracellular environment 
by keratinocytes in the skin.  In the intestinal epithelia of the mouse, the deletion of Cdc42 affected 
several morphogenetic processes, resulting in hyperplasia, abnormal epithelial permeability, 
irregular migration and altered cell differentiation (10).  These studies, along with many others, 
have begun to illuminate multifaceted roles played by Cdc42 not only at the cell-signaling level, 
but also at the tissue and/or physiological level where cells must communicate and coordinate with 
one another (Figure 1.2).  By interfering with the critical ability of cells to sense and respond to 
their surrounding tissue environment, Cdc42 conditional-deletion can ultimately result in an 
altered cell-fate and functional status, rendering the tissue ineffective. 
Cdc42 regulates epithelial cell polarity 
Many of the studies of Cdc42 in-vivo share a common denominator in the resultant 
phenotypes, which is an altered cell polarity that leads to tissue-specific defects (8, 10, 49, 55, 58).  
This brings into focus the importance of understanding how epithelial cells sense surrounding 
growth factors, basement membranes, and other cells within the tissue to regulate their processes. 
The evolution of mammalian epithelial cells has resulted in the differentiation of various exquisite 
tissues and organs.  Epithelial cells line the exterior and interior surfaces of mammalian bodies, 
and thereby provide a functional barrier between tissues of the body, or between the tissue and its 
external environment.  To accomplish this, the epithelial cells must establish and maintain a 
synchronous barrier by making contacts with one another in single or multiple layers, such that 
selective diffusion may take place across the formed barrier.  This allows for the passage of some 
molecules through the epithelial sheets, for example nutrients or hormones, but not others such as  
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Figure 1.2.  Cdc42 plays various roles in vivo.  Multiple essential roles for Cdc42 have been 
identified in several in vivo model systems.  Cdc42 has been shown to affect cell polarity, adhesion 
and mitosis in C. elegans and D. melanogaster, and plays roles in cell fate, polarity and growth in 
various tissues in M. musculus. 
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toxins or waste.  These cell-to-cell contacts, as well as the epithelial cells’ attachment to a basement 
membrane, allow single cells to behave in an orchestrated manner to form functional tissues.  The 
establishment and maintenance of these associations between differentiated epithelial cells have 
been shown to exert remarkable effects on cell growth, survival, migration and invasion (59, 60), 
all of which are necessary for tissue-level functionality.  Alterations in these processes in epithelial 
cells have become hallmarks of cancer and, as approximately ninety percent of human cancers are 
derived from epithelial cells (carcinomas), understanding the molecular mechanisms associated 
with epithelial architecture and function becomes focal to developing higher-efficacy cancer 
therapies. 
 One way in which cells associate with each other is through adherens junctions.  Adherens 
junctions represent a primary form of cell-to-cell adhesion, and are established by the homotypic 
binding of cadherins (calcium-dependent adhesion molecules) (61).  In mammalian epithelial cells, 
the extracellular domain of the transmembrane protein epithelial cadherin (E-Cadherin) is able to 
bind to another E-Cadherin protein in a neighboring cell, while the intracellular domain of E-
cadherin can anchor to the actin cytoskeleton via ɑ-catenin and β-catenin (62, 63).  In this way, 
single epithelial cells can join together their cytoskeletons to form a tissue-level organization and 
function.  Multiple associations between E-Cadherin molecules form zipper-like clusters between 
cells, and these clusters are crucial for the formation of epithelial cell layers (64).  As its name 
suggests, E-Cadherin’s homophilic interactions are dependent on calcium binding to a linker 
region between the extracellular domains, such that the depletion of calcium leads to the 
endocytosis of E-Cadherin molecules from the plasma membrane (65–67).  These endocytosed 
molecules are then either recycled back to the plasma membrane to strengthen adherens junctions, 
or they are targeted for lysosomal degradation which then leads over time to weakened adherens 
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junctions.  In this sorting of E-Cadherin molecules, adherens junctions are consistently monitored 
and modulated to allow tissue growth and organization, as well as for tissue healing after injury 
(68, 69).  Interestingly, the loss of E-Cadherin expression is correlated to cancer progression (70–
73), and the expression of E-Cadherin in certain cancers suppresses their invasive and metastatic 
potential (70, 74). 
 The activity of the epithelial growth factor receptor (EGFR) has been shown to regulate 
the stability of E-Cadherin-based adherens junctions, by activating the non-receptor tyrosine 
kinase Src (Sarcoma) (75).  Activated Src is then able to phosphorylate E-Cadherin, leading to 
subsequent ubiquitination by Hakai and lysosomal targeting (76, 77).  Cdc42 has been shown to 
be instrumental in this process by potentiating the EGFR-mediated activation of Src, leading to 
the increased lysosomal targeting and degradation of E-Cadherin molecules (75).  Activated Cdc42 
potentiates EGFR signaling by binding to Cool-1 (Cloned-out-of-library), which binds to the E3 
ubiquitin ligase Cbl (Casitas B-lineage lymphoma), thereby preventing Cbl from catalyzing EGFR 
ubiquitination for subsequent degradation (78).  This interaction between Cbl and EGFR is 
critically important for proper cell and tissue growth, and the deletion of c-Cbl in the mouse results 
in hyperplasia (79).  Interestingly, the loss of E-Cadherin molecules at adherens junctions has also 
been shown to release p120-catenin from the cell membrane and into the cytoplasm (80, 81).  Once 
cytoplasmic, p120-catenin has the potential to activate Cdc42 via the GEF Vav2 (82).  Taken 
together with the previously-mentioned roles for Cdc42 with IQGAP1, these data collectively 
suggest a dynamic mode of steady-state monitoring of E-Cadherin and EGFR by Cdc42 in 
epithelial cells (Figure 1.3).   
 Within our bodies, many organs contain hollow tubules and spheres that are lined by a 
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Figure 1.3.  Cdc42 affects E-cadherin stability through multiple pathways.  E-cadherin (E-
Cad) molecules bind together at adherens junctions between cells that, when bound to the 
cytoskeleton via catenin family members, form a communication network between epithelia.  The 
binding of IQGAP1 to ƅ-catenin inhibits E-cadherin binding to ƅ-catenin, and consequently the 
cytoskeleton, thus destabilizing E-cadherin at the cell membrane.  Cdc42 can prevent this process 
by binding to IQGAP1, which inhibits IQGAP1-ƅ-catenin interactions and thus helps stabilize E-
cadherin at cell-cell junctions.  P120-catenin, when not bound to the cadherin-catenin complex, 
can activate the Cdc42 GEF Vav2.  EGFR activation can cause Src-mediated phosphorylation of 
E-cadherin molecules which, followed by ubiquitylation by Hakai, can lead to lysosomal 
degradation of E-cadherin.  Cbl, a negative feedback regulator of the EGFR, can indirectly mediate 
this process of E-cadherin phosphorylation by Src.  Cdc42, by binding to the Cool1, a negative 
regulator of Cbl, can potentiate EGFR signaling and thus E-cadherin phosphorylation by Src.  
Together these processes represent a complex network of adherens junction maintenance through 
Cdc42 signaling. 
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Figure 1.3 
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layer of polarized epithelial cells that establish and maintain these adherens junctions.  The 
functions of these organs are dependent on compartmentalizing molecules, a process that relies 
heavily on the formation of barriers by epithelial cell linings.  To form and maintain these barriers, 
some epithelial cells must establish what is known as an apical-basal polarity, such that a basal 
surface is established near the basement membrane formed within the tissue, and an apical surface 
establishes on the opposing side of the cell where a central lumen exists (Figure 1.4A).  This type 
of cellular architecture allows for the vectorial secretion of fluids and molecules, such as saliva or 
milk, into the central lumen, but not into the surrounding cells or tissues.  The polarized distribution 
of ion channels, transporters and pumps within the plasma membrane generates an apical-basal 
sodium gradient that helps to achieve this vectorial movement of molecules and solutes.  Like 
adherens junctions, the maintenance of this type of epithelial apical-basal polarity is lost in 
carcinoma development, and is thought to be a powerful regulator of cell growth and invasive 
migration (83–87).  Apical-basal polarity is established and maintained in epithelial cells primarily 
by three evolutionarily-ancient cellular machineries:  the polarized trafficking machinery, which 
sorts and delivers proteins and lipids to particular cellular locations; the domain-identity 
machinery, which employs highly-conserved polarity proteins and lipids to generate tight junctions 
between the cell’s apical and basolateral domains; and the three-dimensional organization 
machinery, which receives and coordinates extracellular signals to control cell growth and 
cytoskeletal organization.   
 Along with adherens junctions providing cell-to-cell sensing, apical-basal polarized 
epithelial cells in vertebrates also form tight junctions between one another, localized toward the 
apical surface.  Tight junctions employ molecules like claudins and occludins which form strands  
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Figure 1.4.  Epithelial organization within ductal tissues relies on apical-basal polarity, which 
is maintained by polarity complexes within the cell.  A)  Ducts within tissues are comprised of 
epithelial cells (blue) that organize together to form a central lumen (upper diagram), which 
requires apical-basal cell polarity (lower diagram).  The apical surfaces of the epithelial cells 
together form the central lumen, while the basal surfaces adhere to the basement membrane (red).  
B)  Apical-basal polarity is maintained within the epithelial cell by mutual-exclusion actions of 
polarity complexes: the Par, Crumbs and Scribble complexes.  Mutual exclusion is achieved by 
members from these complexes phosphorylating each other, for example aPKC can phosphorylate 
and exclude Lgl from the apical surface of the cell and, conversely, Lgl can phosphorylate and 
exclude Par and Crumbs complex members from the basal surface. 
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between the cells and anchor to their cytoskeletons via binding to zona occludens 1 (ZO-1) 
molecules (88).  The tight junctions provide a paracellular barrier function between the apical 
surfaces of cells, allowing the passage of select solutes and molecules, and they mark the division 
between the apical and lateral surfaces of epithelial cells.  While many molecules are part of the 
tight junction, its assembly and maintenance have been shown to be dependent on the concerted 
actions of Par3 (Partitioning-defective 3), Par6, and Cdc42 (89, 90).   
 Three main molecular complexes, referred to as the Par, Crumbs, and Scribble complexes, 
are associated with the establishment and maintenance of epithelial apical-basal polarity (91, 92).  
In mammalian epithelia, these complexes can work in a fascinating mutual-exclusion relationship 
with one another, such that members of the Par complex exclude members of the Scribble complex 
from the apical cell surface, and conversely, members of the Scribble complex exclude members 
of the Par complex from the basal or lateral cell surfaces (93) (Figure 1.4B).  This mutual-exclusion 
feedback mechanism allows epithelial cells to form an apical-basal polarity with distinct enzyme-
activity zones.  Along with the multiple roles shown for Cdc42 in organizing the cytoskeleton of 
the cell, it has also been shown that Cdc42 can directly affect the polarization of cells (91), i.e. the 
front-rear morphology found in migrating cells, as well as the apical-basal morphology found in 
some differentiated epithelia.  The groups of Cdc42 effectors that are involved in acquiring these 
two separate types of polarity are surprisingly similar, underscoring their importance in a disease 
such as cancer, in which invasive cancer cells that give rise to metastases have shifted from the 
differentiated epithelial cell apical-basal polarity into an invasive front-rear polarity.   
 The core of the apically-localized Par complex consists of Par3, Par6, and atypical protein 
kinase C (aPKC) molecules (94, 95).  In this complex, Par6 functions in recruiting substrates for, 
as well as regulating the kinase activity of, aPKC (94, 96).  Activated aPKC can phosphorylate 
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molecules such as Lethal Giant Larvae (Lgl) (97), thereby excluding their attachment and activity 
at the apical cell surface.  This results in the localization and activity of Lgl only at basal and lateral 
cell surfaces.  Here, Lgl performs a similar, but inverse, function to aPKC by excluding Par6 
activity at the basal and lateral cell surfaces (49).  The concerted activities of these members of the 
polarity complexes result in a steady-state of apical or basolateral molecular localizations, 
affecting numerous enzyme activities, trafficking, and membrane lipid composition. 
 Apical-basal-polarized cells also attain unique phosphoinositide enrichment in their apical 
and basolateral plasma membranes. The apical surface of an epithelial cell is PIP2-rich due to the 
actions of PTEN (for phosphatase and TENsin homolog) (98).  This PIP2-rich plasma membrane 
at the apical surface is then capable of recruiting and bringing together molecular complexes that 
contain Cdc42, its GEFs and effectors (85).  Cdc42 has been shown to bind directly to Par6, and 
this interaction is essential for the apical localization of Par6 (99, 100), which then further leads to 
the recruitment and activation of aPKCζ.  Phosphoinositide 3-Kinase (PI3K) performs an opposing 
effect to PTEN, in that it can phosphorylate the third carbon of the inositol group of 
phosphoinositides, converting PIP2 into PIP3.  Activated aPKCζ has been shown to impair PI3K 
signaling, thereby keeping the apical plasma membrane enriched for PIP2.  In this way, Cdc42 has 
effects on the balance of apical and basolateral membrane composition, molecular complex 
localization and, consequently, epithelial cell apical-basal polarity.   
However, the Par polarity complex is not exclusively used by differentiated epithelial cells 
to establish apical-basal polarity.  The same Par complex has been shown to localize at the leading 
edge of migrating epithelial cells (101–103).  Integrin binding and focal adhesion stabilization at 
the cell’s leading edge recruits Cdc42, and again leads to aPKC activation through Par6 (46, 104).  
In this case, however, activated aPKC then phosphorylates its substrates within range of the 
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leading edge, one of which is glycogen synthase kinase 3β (GSK3β) (105).  When GSK3β is 
phosphorylated at an inhibitory serine residue, it then dissociates from its binding partner APC 
(adenomatous polyposis coli).  When not bound to GSK3β, APC gains the ability to bind to 
microtubules at their (+) ends and anchor them at the plasma membrane, allowing polarized 
migration and a front-rear cell morphology.  IQGAP1, an effector for Cdc42 previously mentioned 
for its effects on E-Cadherin stability at adherens junctions, can also interact with APC, CLIP-170, 
Rac1 and Cdc42 at the leading edge of a migrating cell (106, 107).  This complex is thought to 
orient and stabilize microtubules at the leading edge to form lamellipodia into which vesicles can 
be trafficked for further migration and invasion, as well as to provide the microtubule stability that 
is needed for dynein-dynactin motor complexes to reorient the microtubule organization center 
and Golgi network toward the direction of migration (108).  These critical cellular functions in 
apical-basal versus front-rear polarization display the multifaceted nature of Cdc42 in cell 
signaling and emphasize the importance of its proper use in epithelial cells of the human body. 
 Alternative to the static architecture found in much of the epithelia within our tissues, some 
epithelial cells must move within a tissue from one location to another.  This movement, or 
migration, allows for the dispatchment of the cell from its former locus and cell-to-cell contacts 
into a new area of the tissue, where it can then establish a new set of cell-to-cell contacts.  This 
entire process of transdifferentiation can be described in two phases:  first an epithelial-to-
mesenchymal transition (EMT), and then a mesenchymal-to-epithelial transition (MET).  
Epithelial cells are distinguished by their ability to adhere to one another and form partitions, or 
barriers, within the tissue while mesenchymal cells have weak adherence to one another which 
allows them to be motile within the tissue.  The employment of these two processes is critical 
throughout embryogenesis, organogenesis and adult wound-healing, but the improper 
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transdifferentiation of cells can also contribute greatly to the pathologies of cancer metastasis 
(109). 
 During EMT, several distinct cellular biochemical changes occur which allow the apical-
basal polarized cell to break down its contacts to adjacent epithelia and attain mobility with a front-
rear (directional) polarization.  These changes include transcription factor activation leading to 
gene and microRNA expression, extracellular matrix (ECM) degradation, and the reorganization 
of the cytoskeletal network of the cell (110).  Previous studies have shown Snail to be a major 
player during EMT, originally by its ability to repress E-Cadherin expression by binding to 3 E-
boxes within the E-Cadherin gene promotor (111), and more recently by its ability to repress the 
expression of Crumbs3 (112).  Interestingly, E-Cadherin and Crumbs have been shown to have 
tumor suppressing characteristics, and the loss of their expression is linked to human tumorigenesis 
(113–116) . 
 In some instances, cell migration requires the breakdown of the basement membrane 
proteins that line the basal side of the epithelial sheets.  Migration through this dense matrix of 
basement membrane proteins is termed invasion, and requires the invading cell to release matrix 
metalloproteinases (MMPs) which degrade the extracellular matrix at the leading edge.  While 
epithelial cell invasion occurs at low levels in adult tissues, and therefore MMP expression is low 
in healthy adults, the aberrant activation of MMP expression and cell invasion can facilitate the 
metastasis of cancerous cells within the body (117).  As Cdc42 has been shown to modulate the 
cytoskeleton of cells through various mechanisms, its potential effects on migration and invasion 
in cancer cells have also been examined.  The contributions of Cdc42 toward breast cancer cell 
migration and invasion are not fully understood, however, and recent data indicate that it may play 
contradictory roles depending on the cancer cell type.  One group has shown that the knock-down 
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of Cdc42 in Hs578T cells, a moderately metastatic breast cancer, inhibited migration and invasion.  
However, in the same study, using MDA-MB-231 and C3L5 cells, which are highly metastatic 
breast cancer cell lines, the knock-down of Cdc42 enhanced migration and invasion (118).  This 
group went further to show that the knock-down of Cdc42 in these highly metastatic cell lines led 
to increased phosphorylation of Protein Kinase C-δ, Protein Kinase A, and extracellular signal 
regulated kinase 1/2 (ERK 1/2).  The overexpression of Cdc42 in these breast cancer cell lines 
showed the same confliction of results by inhibiting migration and invasion in the highly metastatic 
cells, but stimulating migration and invasion in the moderately metastatic line.   
 The second phase of transdifferentiation is an inverse process to the EMT, where a 
mesenchymal cell transitions back into an epithelial cell.  The migrating mesenchymal cell ceases 
its movement within a tissue and shifts its front-rear morphology into an apical-basal polarized 
morphology and establishes cell-to-cell contacts via adherens and tight junction formation.  This 
transition completes the transdifferentiation cycle and demonstrates how epithelial plasticity is 
complex but essential to tissue formation and homoestasis (119).  However, cells that lose the 
proper control over these transdifferentiation programs become detrimental to their surrounding 
tissues, as is evidenced in the case of metastatic cancer cells.  These cancerous cells not only grow 
abnormally and fail to perform proper tissue functions but, upon undergoing EMT, they are 
capable of spreading to surrounding tissues, including blood.  Once in the blood circulation, this 
type of cancer cell then has the potential to metastasize to other parts of the body, which has 
garnered the attention of cancer researchers to better understand the process of EMT for potential 
therapeutic intervention points. 
Cdc42 deregulation in the progression of cancer 
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 Cdc42 is found to be overexpressed in multiple forms of cancer (13, 120–123), including 
certain invasive ductal carcinomas of the breast.  Cdc42 has been shown to promote tumorigenesis 
in several ways, in particular by activating PAK (124, 125), PI3K (126, 127),and mTOR 
(mechanistic target of rapamycin) (128–130), as well as by inducing the expression of glutaminase 
C (131) to alter cell metabolism, growth and cytoskeletal remodeling.  Cdc42 also affects the cell’s 
DNA damage response, as evidenced by a study targeting the deletion of Cdc42GAP in mice.  By 
deleting a negative regulator of Cdc42, this group showed that mice had elevated Cdc42 activity 
accompanied by premature aging characteristics with dampened DNA damage repair (132).   
Cdc42 has also been shown to play a role in the growth signaling of primary mouse embryonic 
fibroblasts that have lost the expression of p53, a known tumor suppressor (133).  With such a 
significant array of potential signaling outputs to regulate cell growth and function, the studies of 
Cdc42 in cancer have become enormous in number, and have underscored the weight of this 
protein’s cellular impacts. 
The Cerione laboratory has been heavily involved in studying the mechanisms by which 
Cdc42 is regulated in the cell, from its activation by GEFs to its de-activation by GAPs and 
sequestration by GDIs. The proto-oncogene Dbl (diffuse B-cell lymphoma) functions as a GEF for 
Cdc42, and a truncated mutant lacking the N-terminal 497 residues results in the deletion of an 
auto-inhibitory motif, thereby resulting in an oncogenic version of Dbl (onco-Dbl) that is capable 
of hyperactivating Cdc42 (134).  Expression of onco-Dbl has also been shown to confer cancer-
like properties to NIH 3T3 fibroblast cells (18, 135), prompting questions about the role of Cdc42 
during this process.  To better understand the cellular effects of excessive Cdc42 signaling, several 
activating-mutants of Cdc42 were created.  In these studies, it was noticed that mutants which 
enabled the accelerated cycling of nucleotide-binding to Cdc42 were capable of promoting cellular 
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transformation, as opposed to GTP-hydrolysis-defective mutants that locked Cdc42 in a 
persistently active, GTP-bound state (136).  One of these so called “fast-cycling” mutants, 
Cdc42[F28L], was shown to be capable of GTP hydrolysis, while exhibiting constitutive GDP-
GTP exchange.  In a cellular environment, the levels of GTP are approximately ten-fold higher 
than the levels of GDP, thus enabling the Cdc42[F28L] mutant to bind to GTP following GDP 
release, thereby increasing the cellular pool of GTP-bound Cdc42.  The Cdc42[F28L] mutant was 
also able to confer onto NIH 3T3 fibroblasts several hallmarks of cancer including the ability to 
grow in low serum and in the absence of a substratum (15).  ERK activity was shown to be elevated 
in the presence of Cdc42[F28L], as a result of sustained EGFR signaling (78).  Interestingly, GTP-
hydrolysis-defective mutants of Cdc42, which are dominant-active, do not convey the same 
characteristics of transformation to NIH 3T3 cells.  Rather, these dominant-active Cdc42 mutants 
appear to be growth-inhibitory or toxic in this cell line (136, 137).  
Mammary gland evolution and function 
Along with epithelial cells forming the barriers within our body, glandular structures are 
also composed of epithelial cells, both in the cysts and tubules that form the functional units within 
glands.  In the case of a secretory gland such as the mammary gland, these cysts, or alveoli, undergo 
rapid expansion upon pregnancy and become high-output milk producing factories upon 
parturition.  Carl Linnaeus originally assigned the Class Mammalia in 1758, and did so primarily 
based on the presence of the mammary glands that distinguish us from other vertebrates.  Since 
then, approximately 5000 species of mammals have been defined, and are diversified to swim, run, 
or fly.  While epithelial cells emerged in metazoans approximately six-hundred million years ago, 
the mammary gland is an evolutionarily recent feature derived from the ectoderm and found in the 
past two-hundred million years of life.  The evolution of secretory mammary tissue has provided 
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a unique advantage to survival, as the components of milk are capable of completely nourishing 
neonates without any other food source.  To produce this complete form of nutrition in copious 
amounts that can sustain the growth of one, two, five, or even ten nursing youth, enormous 
quantities of energy are required from the mammalian mother, both for the morphogenesis of the 
secretory tissue during pregnancy, as well as for the synthesis of large volumes of milk during 
lactation.  The level of required cellular control over growth, mitosis, migration, apoptosis and 
secretion throughout pregnancy and lactation is staggering to consider, and many elegant studies 
have elucidated in great detail how the mammary gland has evolved to accomplish this (138–140). 
While the virgin mammary gland is composed predominantly of adipocytes with only a 
rudimentary epithelial tree ingrown from the nipple, the onset of pregnancy will induce the rapid 
proliferation and expansion of the epithelia, particularly the alveolar luminal cells that will 
synthesize milk proteins and fats.  By the time-point of parturition, the mammary gland, once 
comprised of mostly adipocytes, becomes an epithelial cell-rich secretory organ capable of 
producing copious amounts of milk to support the rapid growth rates of the nursing neonate(s).  
Depending on the varying lengths of lactation time in species, this stage of mammary gland 
maturity will continue to provide complete nourishment to the nursing youth until they reach an 
age at which they can hunt or forage for food.  Tight control over the cell-cycle must be maintained 
during this stage, as the secretory cells must produce many milk lipids and proteins but not enter 
mitosis. 
While its hyper-activity has been linked to the progression of cancerous transformation in 
cells (12, 15), Cdc42 has also been shown to affect normal mammary gland developmental 
functions as well (141, 142).  This suggests that the general inhibition of Cdc42 may not be an 
ideal therapeutic approach to breast cancer, but rather the targeting of select Cdc42 signaling could 
27 
 
prove to be beneficial.  To better understand the roles of Cdc42 in mammary epithelial cells, loss-
of-function as well as overexpression studies have been performed in the mouse during the 
morphogenesis of the gland.  Primary mouse mammary epithelial cells (MECs) showed stunted 
proliferation rates and reduced survival when cultured in the absence of Cdc42 expression (142).  
Cdc42-deficient MECs also failed to form organized alveolar acini, due to deficiencies in 
establishing apical-basal cell polarization and improper mitotic spindle orientation during division.  
Surprisingly, the defects in proliferation and survival were only seen when primary MECs were 
grown in a three-dimensional substratum, and not in monolayer conditions.  This key point further 
underscores the impact of the extracellular environment on Cdc42-mediated cell signaling during 
tissue development, function and maintenance.   
Conversely, the overexpression of Cdc42 in the developing mammary gland results in 
hyper-budding and trifurcation in the terminal end bud units, with increased ductal side-branching 
(143).  These alterations in the development of the mammary gland were not caused by changes 
in cell proliferation or survival, but rather by an increase in cell migration via mitogen-activated 
protein kinase (MAPK) signaling.  These phenotypes were also accompanied by changes in the 
stromal environment of the epithelial bed, illustrating the nature of the functional dependence 
among cell types within the mammary gland.  When combining the results from these studies with 
those examining Cdc42 function in other tissues of the mouse, Cdc42 signaling can be described 
as essential for not only the function of an individual cell, but also for the concerted efforts of cells 
that work to together at the tissue-level. 
Summary 
While the studies described above have shown significant importance for proper Cdc42 
signaling during early stages of development in the mammary gland, much less is known about 
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the potential roles of Cdc42 during the maintenance of function of the adult-stage mammary gland.  
As breast cancer is a disease primarily afflicting adult women, I began the work presented in this 
dissertation by investigating the potential roles of Cdc42 in the adult-stage mouse mammary gland.  
I performed this by using a loss-of-function approach in adult mouse mammary glands, with the 
goal of identifying the cellular and tissue changes that accompany this loss of Cdc42 expression. 
The conditional deletion of Cdc42 in adult lactating mammary glands resulted in abnormal 
cell-to-cell communication, due to a loss of proper adherens junctions and apical-basal cell 
polarity.  The loss of proper adherens junctions between the mammary epithelial cells was caused 
by changes in E-cadherin localization and expression, and I reasoned this to be related to aberrant 
IQGAP1 activity in the absence of Cdc42.  The loss of apical-basal cell polarity was caused by a 
loss of Par6 localization at the apical surface of the mammary epithelial cells, accompanied by 
aPKCζ mislocalization.  Overall, this led to a disorganized architecture within the epithelial 
compartment of the adult mammary gland, and the cells that lost Cdc42 expression began to 
prematurely slough off into the central lumens of the alveoli.  This phenotype led to stunted 
lactation potential in the female mice, and demonstrated the essential roles for Cdc42 in the adult 
mammary gland.  This model system allowed us to visualize which of the many potential roles of 
Cdc42 were relevant to adult-stage mammary gland function.  I then wanted to use this information 
to further probe the effects exerted by Cdc42 during breast cancer progression, and possibly 
identify how the roles for Cdc42 shift during the process of transformation. 
To accomplish this, I employed a primary cell culture model system that allowed for the 
isolation of mammary epithelial cells from mice which would then be cultured in either monolayer 
or three-dimensional (3D) conditions.  The deletion of Cdc42 in the 3D model system resulted in 
a phenotype that corroborated with our lack-of-function mouse model, in that disorganized 
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mammary alveoli formed, consisting of epithelial cells that abnormally occupied the central lumen 
space.  However, the addition of the hyper-active Cdc42[F28L] mutant to the cells in this model 
system showed an intriguingly different result.  While the lack of Cdc42 in MECs, both in the 
three-dimensional cell culture and mouse systems, resulted in significant changes in cell-to-cell 
communication and organization, the addition of the hyper-active mutant of Cdc42 resulted in 
disorganized mammary epithelia that showed invasive characteristics.  The invasive nature of the 
MECs that expressed Cdc42[F28L] was dependent on Cdc42 signaling to IQGAP1, highlighting 
this effector as a major player in Cdc42 signaling in the mammary gland.  Cdc42[F28L] expression 
in the primary MECs resulted in invasive projections extending out into the laminin-rich 
extracellular matrix.  These invadopodia progressed into the surrounding extracellular matrix, 
leading to further cellular migration and invasion away from the primary site of cell growth.  The 
phenotypes attributed to the primary MECs in the presence of Cdc42[F28L] are of relevance to 
cancer biology, as not only are the cells disorganized, but they are invading out into their 
surroundings.   
As the stages of breast cancer advance from ductal carcinoma in-situ to invasive ductal 
carcinoma, cancer cells within the tumor gain the ability to invade surrounding tissue, potentially 
reaching the lymphatic or blood flow and metastasizing.  As Cdc42[F28L] expression caused 
normal, differentiated MECs to adopt an invasive phenotype, the role of Cdc42 hyperactivity 
during this process will be further examined.  In particular, I am interested in knowing whether 
there is a hijacking by Cdc42[F28L] of the role of IQGAP in bundling microtubules at the plasma 
membrane of cells to aid migration and invasion, as well as in increasing the degradation of E-
Cadherin via increased Src activity.  These data place Cdc42 as a type of biosensor in mammary 
epithelial cells, where variances in the levels of its activity and localization leads to selective 
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binding to effectors that can promote shifts from static, strongly-adhered cells into motile, weak-
adhesion cells and back again.  
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Chapter 2 
 
An Essential Role for Cdc42 in the Functioning of the Adult Mammary Gland 
 
Abstract 
The Rho family small GTPase Cdc42 has been implicated in a wide range of cellular 
functions including the establishment of cell polarity and the remodeling of the actin cytoskeletal 
architecture, resulting in the tight regulation of cell growth and survival during developmental 
processes. The complete knock-out of Cdc42 in the mouse is embryonic-lethal, and its targeted 
deletion in various tissues has been shown to disrupt tissue homeostasis.  Thus far, in most 
studies, the targeted deletion of Cdc42 occurred during embryogenesis.  Here, we have used a 
conditional gene deletion strategy in mice to probe the specific role of Cdc42 during adult 
mammary gland function. Cdc42 conditional-knock-out females were unable to adequately 
nourish their pups, due to a disorganized epithelial compartment within their mammary glands. 
A closer examination showed that their mammary epithelial cells were not able to maintain 
functional alveolar lumens, due to an inability to establish normal apical/basal epithelial polarity, 
as well as proper cell-cell contacts. Loss of these essential epithelial characteristics led to a 
premature sloughing off of the Cdc42-null epithelial cells.  Overall our findings demonstrate that 
Cdc42 plays essential roles in mammary gland function post pregnancy, where it helps to 
establish proper epithelial cell polarity and tissue homeostasis during lactation. 
 
-The research described in Chapter 2 is from Druso, JE et al. (2016). J. Biol. Chem. 291, 8886-
8895 
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Introduction 
The Rho family GTPase Cdc42 has been shown to function as a key regulator in 
establishing and maintaining epithelial structures in a broad spectrum of multi-cellular organisms,  
ranging from Caenorhabditis elegans to Homo sapiens (1-3).  In vitro two-dimensional (2D) and 
three-dimensional (3D) cell culture systems have provided molecular insights into how Cdc42 
regulates the establishment and maintenance of epithelial cell polarity and morphology.  In 2D 
cultures of Madin-Darby canine kidney (MDCK) cells, Cdc42 was shown to be involved in the 
maintenance of epithelial cell morphology, by regulating polarized membrane transport, cell-cell 
adhesion, and cytoskeletal remodeling (4).  Studies using a 3D cell culture system comprised of 
MDCK cells suggested that Cdc42 is necessary for proper apical membrane specification (5,6), 
while an analogous system using colorectal carcinoma Caco-2 cells showed that Cdc42 regulates 
directional vesicular trafficking and mitotic spindle orientation, but not apical-basal cell polarity 
during cyst formation (7).  Together, these findings demonstrate that Cdc42 regulates epithelial 
cell morphology at multiple levels, and that its specific functional roles are dependent on the 
cellular context.   
Those actions of Cdc42 that ensure the proper maintenance of epithelial structures served 
as a forecast of critically important functions for this GTPase in various developmental 
processes.  Indeed, a number of studies using conditional knock-out (CKO) mice have shown 
that the deletion of Cdc42 in epithelial stem/progenitor cells from a variety of tissues results in 
the disruption of intact epithelial structures, leading to severe and even lethal defects in 
embryonic organogenesis and tissue homeostasis (8,9).  Defects in epithelial structure that 
accompany the deletion of Cdc42 have been suggested to affect cell fate determination, 
proliferation, survival, and differentiation during embryonic development (10-14).   
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The importance of Cdc42 in the development of the mammary gland, prior to pregnancy, 
has been suggested from studies using transgenic mice, as well as from experiments performed 
with primary epithelial cells derived from conditional knock-out mice.  The virgin mouse 
mammary gland contains sparse ductal networks that extend into the mammary fat pad and 
culminate in terminal end bud units.  Upon pregnancy, the mammary gland becomes a high-
output secretory tissue, largely through the signaling cues of prolactin and progesterone, which 
instruct the virgin epithelial bed to undergo rapid proliferation to fill the entire mammary fat pad 
with alveoli that are capable of milk secretion (15).  At the time of parturition, luminal epithelial 
differentiation and lactogenesis begin within the alveoli, and continue through the early stages of 
newborn life, providing sufficient nutrients to sustain the significant and rapid growth rates of 
the suckling neonates.  After weaning, the expanded milk-producing alveoli undergo massive-
scale apoptosis, termed involution, with the entire mammary gland regressing back to a pre-
pregnancy-like state, awaiting the next round of pregnancy and lactation (15). 
The inducible expression of Cdc42 in pre-pregnant mammary ductal epithelial cells 
caused hyper-branching of mammary ducts and deformation of terminal end bud units (16).  A 
modest increase in Cdc42 expression (1.5 fold) was sufficient for pre-pregnant mammary ductal 
epithelial cells to exhibit more invasive phenotypes, thus suggesting that the tight regulation of 
Cdc42 function is essential for this stage of mammary gland development (16).  Studies in 3D 
cell culture model systems, using pre-pregnant stage primary mammary epithelial cells, showed 
that the deletion of Cdc42 inhibited acinar formation by causing defects in apical-basal cell 
polarity, cell-cell contact, mitotic spindle orientation, cell proliferation, and cell survival (17).  
Additionally, the expression of the dominant negative Cdc42(T17N) mutant also inhibited the 
establishment of acinar structures and, consequently, prolactin-dependent synthesis of milk 
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proteins in mammary epithelial cells (18).  However, introducing the Cdc42(T17N) mutant into 
established acini did not affect prolactin-induced milk production, suggesting that Cdc42 is 
essential for establishing acinar structures but not for milk production in mammary acini (18).   
While the studies described above show that Cdc42 plays an important part in normal 
mammary development before pregnancy, thus far, it has not been demonstrated whether Cdc42 
exerts additional in vivo functions during the entire process of lactation.  Therefore, in order to 
investigate the importance of Cdc42 in mammary alveolar epithelial cells during lactation, we 
generated conditional knock-out mice in which Cdc42 is deleted specifically in milk-producing 
alveolar epithelial cells.  This was achieved by crossing floxed Cdc42 (Cdc42flox/flox) mice with 
transgenic mice expressing Cre recombinase under the control of the whey acidic protein (WAP) 
promoter (19).  We found that the deletion of Cdc42 in the lactating alveolar cells of female mice 
prevented them from being able to sufficiently nourish their pups.  This was due to a severe 
impairment of mammary alveoli formation, resulting from the loss of intact luminal epithelial 
structures and premature cell sloughing.  Interestingly, alveolar cells in Cdc42 conditional 
knock-out (CCKO) lactating mammary glands still maintained their function as milk-producing 
cells, and did not exhibit significant defects in cell proliferation and survival during lactogenesis, 
nor did they show any sign of cellular apoptosis even within the time window when control 
glands underwent the early stages of involution.  When taken together, our current findings show 
that the ability of Cdc42 to establish cell polarity and cell-cell contacts plays an essential role in 
ensuring the proper homeostasis of lactating mammary glands.  Moreover, they demonstrate that 
Cdc42 is a key regulator of mammary gland development and function, not only during the pre-
pregnancy developmental stage, but also during the post-pregnancy period of lactogenesis. 
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EXPERIMENTAL PROCEDURES 
Mouse strains and husbandry- Mice used in this study were housed and handled in 
accordance with the Cornell University Institutional Animal Care and Use Committee (IACUC).  
Cdc42flox/flox mice (controls) were crossed to WAP-Cre(+) Cdc42wt/flox mice to generate 
conditional deletion females genotyped as Cdc42flox/flox ;WAP-Cre(+).  These females were then 
mated at the age of eight weeks, and removed from their breeding partner male after a mating 
plug was observed.  For fostering experiments, litters were fostered to a timed mating-matched 
mother on day one post-partum.   
For pup growth experiments, litter size was normalized to 6 pups by fostering, and then 
each pup was tail marked for identification.  The mass of each pup was recorded daily until the 
age of 21 days, at which point they were weaned from their mother and placed on standard 
rodent chow.  Pup growth measurement was repeated for five litters, resulting in the 
measurement of 30 pups total for each strain of mouse.   
For tissue collection, mice were euthanized by carbon dioxide inhalation, and then the 
fourth pair of mammary glands was harvested. 
Antibodies- Antibodies used for Western blotting and immunohistochemistry or 
immunofluorescence were purchased from the following companies: anti-Cdc42 (ab64533), anti-
Ki67 (ab15580), anti-aPKCζ (ab4139), anti-N-Cadherin (ab12221), anti-Twist (ab50581), anti-
Cytokeratin 8 (ab59400), anti-TGFβ1 (ab92486), and anti-Cytokeratin 14 (ab53115) antibodies 
were from Abcam Inc; anti-phospho-Stat 5 (CS9359), anti-Snail (CS3879), anti-vinculin (CS 
4650), anti-phospho-SMAD 2/3 (CS8828) and anti-E-Cadherin (CS3195) antibodies were from 
Cell Signaling Technology.  Anti-cleaved caspase-3 (AB3623) antibody was purchased from 
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EMD Millipore, anti-β-actin (MA5-15739) was purchased from ThermoFisher Scientific, and 
anti-Par 6 (25525) antibody was obtained from Santa Cruz Biotechnology.  
SDS-PAGE and Western blot analyses- Immediately following euthanasia, the fourth pair 
of mammary glands was harvested from mice, frozen in liquid nitrogen, and ground using a 
mortar and pestle.  The tissue powder was then suspended in triple detergent buffer (150 mM 
NaCl, 50 mM Tris-HCl, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, 0.02% 
sodium azide, 1 mM sodium vanadate, pH 8.0) with protease inhibitors (10 µg/mL leupeptin, 10 
µg/mL aprotinin) and incubated on ice for 20 minutes.  The extracted proteins were centrifuged 
at 13,000 rpm for 15 minutes at 4° C, after which the supernatant was removed and used for 
BioRad protein assays.  Samples were subjected to polyacrylamide gel electrophoresis and 
transferred onto polyvinylidene fluoride membranes (Perkin Elmer).  The membranes were 
blocked using 5% milk, and incubated overnight on a rocker at 4° C with the primary antibodies 
at a dilution of 1:1000.  Membranes were then washed three times for five minutes in TBST, and 
incubated with horseradish peroxidase-conjugated secondary antibodies (GE Healthcare) for 1 
hour, after which an ECL reagent (Perkin Elmer) was used to obtain chemiluminescence of the 
signal onto x-ray film. 
Whole mount staining- Whole mount staining of the entire mammary gland was 
performed by spreading the gland onto a Superfrost Plus slide (VWR) and then placing another 
slide on top.  These two slides were compressed together for 15 minutes, with the mammary 
gland between them, using two 2-inch binder clips.  The top slide was then removed and the 
mammary glands were fixed in Carnoy’s fixative (6 parts 100% ethanol, 3 parts chloroform, 1 
part glacial acetic acid) for 6 hours, after which they were rehydrated using a succession of 20-
minute ethanol washes (70%, 50%, 25%), and finally, distilled water.  Epithelial staining was 
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achieved by submerging the mammary glands (still mounted on one slide) in carmine aluminum 
staining solution, containing 0.2% carmine aluminum, 0.5% aluminum potassium sulfate, and a 
thymol crystal, overnight at room temperature.  After staining, the tissues were dehydrated by 
performing 20-minute ethanol washes (70%, 95%, 100%), followed by clearing of the tissue 
through two 20-minute washes in mixed xylenes, and mounted and coverslipped using Permount.  
Imaging was performed using an Olympus SZ-11-CTV dissecting microscope fitted with an 
Olympus Camedia C-5050 digital camera. 
Immunohistochemistry and immunofluorescence- The fourth pair of mammary glands 
were harvested from pregnant or lactating females, rinsed briefly in PBS, and fixed in 4% 
paraformaldehyde for 15 hours at 4° C.  These glands were embedded in paraffin, sectioned at 5 
µm thickness, and placed onto VWR Superfrost slides.   
For immunohistochemistry staining, the tissue sections were deparaffinized and 
rehydrated, and subjected to heat-induced epitope retrieval (HIER) using either an EDTA buffer 
(10 mM Tris base, 1 mM EDTA, 0.05% Tween 20, pH 9.0) or a sodium citrate buffer (10 mM 
sodium citrate, 0.05% Tween 20, pH 6.0).  Antigen retrieval buffers were heated to 95°C, at 
which point sample slides were added, and then kept at 95° C for 15 minutes to induce antigen 
retrieval.  Slides were left in the heated antigen retrieval buffer to cool at room temperature for 
15 minutes, after which they were rinsed using three 5-minute PBS washes.  Samples were 
processed using an ImmunoCruz ABC staining kit (Santa Cruz) along with the primary 
antibodies, dehydrated by 5-minute washes with varying amounts of ethanol (70%, 95%, 100%), 
cleared by two 5-minute washes of mixed xylenes, and mounted with Permount (Fisher 
Scientific).  Imaging was performed using an Olympus AX70 compound microscope equipped 
with a MicroFire camera and PictureFrame image processor (Optronics). 
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For immunofluorescence staining, tissue sections were deparaffinized, rehydrated, and 
subjected to HIER as above, and then blocked in 10% bovine serum albumin in PBS for one hour 
at room temperature in a moisture chamber.  Primary antibody dilutions were added to the 
samples, which were replaced in the moisture chamber and incubated for 15 hours at 4° C.  
Samples were then removed from the primary antibody dilutions, and rinsed in four 5-minute 
PBS washes, followed by incubation in Alexa Fluor 594-conjugated antibody (Life 
Technologies) for one hour at room temperature in a moisture chamber.  Samples were rinsed in 
three 5-minute PBS washes, and incubated in 4,6-diaminodino-2-phenylindole (Sigma Aldrich) 
at a 1:5000 dilution in double distilled water (ddH2O) for 5 minutes at room temperature.  
Samples were then rinsed using three 5-minute ddH2O washes, and sealed with KPL Fluorescent 
Mounting Media.  Epifluorescence imaging was performed on a Zeiss inverted Axioskop 
equipped with a COOKE Axiocam/Sensicam camera. 
For Fast Green/Sirius Red staining, the tissue sections were deparaffinized by two 10-
minute washes of mixed xylenes (Fisher Scientific), and rehydrated by successive 5-minute 
washes with different amounts of ethanol (100%, 95%, 70%), followed by two 5-minute washes 
with ddH2O.  The tissue sections were then immersed in a solution of 0.1% Fast Green, 0.1% 
Sirius Red, and 1.2% picric acid for 30 minutes at room temperature, dehydrated by 5-minute 
washes with 95% and 100% ethanol, cleared with two 5-minute washes of mixed xylenes, and 
mounted with Permount (Fisher Scientific). 
Primary mammary epithelial cell isolation and 3D culture- The fourth pair of mammary 
glands were immediately harvested from euthanized twelve-week-old virgin Cdc42flox/flox female 
mice.  Following the protocol from Lo et al. (20), the glands were minced briefly with two sterile 
razor blades, then digested at 37° C with 100 rpm rotation in digestion buffer (2 g/l trypsin 
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(Invitrogen), 2 g/l collagenase type-iv (Invitrogen), 5% v/v FBS (Invitrogen), and 5 µg/ml 
insulin (Sigma) in DMEM/F12 medium (Invitrogen)).  Digested mammary glands were then 
centrifuged at 400 g for 15 minutes at room temperature.  The top 15 ml of fat cell-containing 
media were pipetted off and resuspended in DMEM/F12, and then centrifuged again at 400 g for 
15 minutes at room temperature, along with the original resuspended pellet of organoids.  The 
resulting pellets were then resuspended and combined in DMEM/F12 and centrifuged at 400 g 
for 15 minutes at room temperature.  This pellet was resuspended in DMEM/F12 containing 2 
U/µl DNase 1 (Sigma) for 5 minutes at 37 ° C with gentle swirling.  The suspension was 
centrifuged at 400 g for 15 minutes at room temperature, after which the pellet was resuspended 
in DMEM/F12 and pulse-centrifuged twice at 260 g at room temperature.  The pellet was 
resuspended in DMEM/F12 containing 1x Insulin-Transferrin-Sodium Selenite (ITS, Sigma) and 
1x Penicillin/Streptomycin (PS, Invitrogen), and organoids were counted.  The solutions were 
centrifuged at 260 g for 15 minutes at room temperature, after which the pelleted organoids were 
resuspended in Growth Factor Reduced Matrigel (BD Biosciences), and plated in 8-well 
chamber slides at approximately 200 organoids per well. DMEM/F12/ITS/PS (300 µl) were 
added to the top of the matrigel, and the organoids were cultured at 37° C and 5% CO2 in an 
incubator overnight.  After 24 hours, the media was exchanged with DMEM/F12/ITS/PS 
containing 9 nM TGFɑ (Sigma).  After 6 days of culture, exchanging the 
DMEM/F12/ITS/PS/TGFɑ media every second day, the organoids formed hollowed alveoli.  
Adenovirus was then added to the media:  control cultures were given Ad–CMV-GFP virus 
(Vector Biolabs) at approximately MOI 80, while experimental cultures were given Ad-Cre-GFP 
virus (Vector Biolabs) at approximately MOI 80.  Cells were imaged on an Olympus CK2 
inverted microscope with an Olympus Camedia C-5050 digital camera. 
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RNA sequencing- The fourth pair of mammary glands was harvested from euthanized 
mice at lactation day 5, and flash frozen in liquid nitrogen and crushed with a mortar and pestle.  
The pulverized tissue was then homogenized using a Qiagen RNA Shredder kit, and RNA was 
immediately extracted using a Qiagen RNeasy kit.  The extracted total RNA was then sequenced 
at the Cornell University Institute of Biotechnology Genomics Facility.  RNA sequences were 
then analyzed using the TopHat Alignment and Cufflinks Assembly software on Illumina’s 
BaseSpace website, and further analyzed using the iPathway Guide. 
RESULTS 
Cdc42 knock-out mothers are unable to sufficiently nourish pups. 
  To knock-out Cdc42 in milk-producing alveolar epithelial cells, we mated Cdc42flox/flox 
mice (21) with transgenic mice carrying a Cre recombinase gene under the promoter region for 
Whey acidic protein (WAP), in which Cre recombinase is expressed specifically in mammary 
alveolar epithelial cells during lactation (Figure 2.1A).  Females that were genotyped either as 
Cdc42flox/flox; WAP-Cre(-) (control), or as Cdc42flox/flox; WAP-Cre(+) (CCKO), were then mated 
to induce pregnancy.  Western blotting of lysates from the fourth pair of mammary glands 
showed a reduction in Cdc42 protein levels in CCKO mothers, compared to controls, as lactation 
progressed (Figure 2.1B).    
  Pups nursing from CCKO females displayed severely stunted growth rates (Figure 2.1C).  
To ensure that this phenotype was due to mammary gland defects in the CCKO mothers, and not 
a result of potential developmental defects in their pups, we fostered pups born to CCKO 
mothers to control mothers at day 1 post-partum, and vice-versa.  Pups born to CCKO mothers 
had normal growth rates when feeding from a control mother (Figure 2.1D), while pups born to 
the control mothers showed growth defects when feeding from a CCKO mother.  After weaning,  
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Figure 2.1.  The conditional deletion of Cdc42 in the lactating mammary gland stunts 
nursing pup growth.  A) Schematic timeline describing the conditional gene deletion strategy 
used in this study, with illustrations depicting the development of the mammary gland in each 
developmental stage.  B) Western blot of tissue lysates showing whole-gland Cdc42 expression 
from the stages of virgin to lactation day 20 (L20), with β-actin serving as a loading control.  C) 
Growth plot depicting average weight of individual pups (n=30) feeding from a CCKO mother 
(blue), or from a control mother (red), throughout lactation.  Error bars represent the standard 
deviation to the mean pup mass at each given time-point.  D) Growth plot depicting average 
weight of individual pups (n=30) that were fostered from a control mother to a CCKO mother 
(blue), or from a CCKO mother to a control mother (red).  Error bars represent the standard 
deviation to the mean pup mass at each given time-point. 
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pups that had nursed from CCKO mothers were able to attain near-normal weights on standard 
rodent chow, and this growth was accelerated when a milk substitute was added to the food (data  
not shown).  As an added control, pups born to a Cdc42flox/wt; WAP-Cre(+) mother were 
 analyzed, and followed the same growth rates as pups nursing from the Cdc42flox/flox;WAP-Cre(-) 
control mothers (data not shown). Thus, the growth defects exhibited by pups were apparently 
due to an inhibited secretory output of the CCKO mothers, and not from developmental defects 
of the pups themselves, nor from Cre expression alone.  The pups nursed from CCKO mothers 
did not exhibit increased mortality, thereby suggesting that CCKO mothers can produce a 
sufficient amount of milk for pup survival, but not enough to support their normal growth.  The 
same growth defects of pups nursing from CCKO mothers were observed in a second round of 
lactation of CCKO mothers, after a complete period of involution (data not shown).  Given these 
findings, we set out to perform a more detailed examination of mammary gland development in 
CCKO mice versus their control counterparts. 
Cdc42 knock-out causes an impaired development of lactating mammary glands. 
We first examined and compared the overall structures of the mammary glands from 
CCKO and control females.  In whole mount images using carmine red staining, both control and 
CCKO mothers showed normal ductal epithelial development before pregnancy, and we did not 
detect any significant difference in ductal elongation, ductal branching, nor in the size and shape 
of terminal end buds (Figure 2.2, panels a and b).  However, as lactation proceeded, especially at 
the end of the lactation phase (lactation day 20), the alveolar units of CCKO females appeared 
significantly underdeveloped, compared to control females (Figure 2.2, panels c and d).  The 
mammary glands of control mothers showed mature, expanded alveoli, whereas the alveoli of  
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Figure 2.2.  Conditional deletion of Cdc42 in mammary glands inhibits normal 
alveologenesis during lactation. Whole mount images of mammary glands using Carmine Red 
staining to visualize the epithelial network in control and CCKO mice in the virgin stage (a,b), 
and at lactation day 20 (c,d).   e,f: Insets from c,d with arrowheads to indicate fully expanded 
alveoli in control mice, or latent alveoli in CCKO mice.  g,h: Fast Green and Sirius Red staining 
depicting the epithelial and collagen basement membrane structures in alveoli sections, 
respectively. Arrowhead in h indicates abnormally sloughing of an epithelial cell.  Scale bars 
represent 50 µm.  The results are representative of the analysis of >3 mice each from control and 
CCKO groups. 
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CCKO mothers showed a significantly latent morphology (Figure 2.2, arrowheads in panels e 
and f).   
A closer examination showed that the luminal epithelial cells of CCKO mothers exhibited 
a single-layered structure surrounded by collagen basement membrane, as displayed by staining 
with Fast Green and Sirius Red, respectively (Figure 2.2, panel h).  Thus, apparently the deletion 
of Cdc42 in mammary alveolar cells did not affect the transition of a multi-layered terminal bud 
unit into a single-layered alveolar epithelium.  However, CCKO mammary glands lacked the 
normal epithelial organization found in control mothers.  Alveolar cells of control mammary 
glands formed a smooth inner luminal surface within each acinus and exhibited a flattened 
squamous epithelial shape (Figure 2.2, panel g).  In contrast, many of the inner luminal surfaces 
of CCKO mammary glands were deformed, and the cells facing alveolar lumens commonly 
showed cuboidal epithelial structures (Figure 2.2, panel h).  We also noticed that several cells in 
the CCKO glands appeared to have sloughed off from the alveolar structures into the inner 
luminal cavity (Figure  2.2, panel h, indicated by arrowhead).   
Since the deletion or loss of Cdc42 function has been shown to cause impairments in cell 
proliferation and increased apoptosis in pre-pregnant mammary ductal epithelial cells (17,18), 
we examined whether the deletion of Cdc42 in mammary luminal alveolar cells resulted in 
similar defects, thereby leading to latent alveologenesis.  Prolactin-dependent signaling is critical 
for the proper morphogenesis and secretory capability of mammary gland cells during pregnancy 
and lactation (15).  Activation of the prolactin receptor results in the phosphorylation and 
activation of STAT5 in lactating mammary glands (22,23).  We found that the phosphorylation 
levels of STAT5 appeared to be maintained and even elevated in CCKO mammary glands in the 
later stage of lactation (e.g. lactation day 20), compared to controls (Figure 2.3A).  These results  
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Figure 2.3. Changes in proliferation and apoptosis in CCKO mammary glands.  A) Western 
blot of whole-gland tissue lysates depicting phosphorylated Stat5 (pStat5) and cleaved caspase 3 
expression throughout lactation in the mammary gland, with β-actin serving as a loading control. 
L5 = lactation day 5; L10 = lactation day 10; L20 = lactation day 20.  B) Immunofluorescence 
staining depicting Ki67 expression (red) in 5 µm-thick sections from the mammary glands of 
CCKO and control mice at lactation day 13 (L13, top row) and lactation day 20 (L20, bottom 
row).  Nuclei are stained blue. Scale bars represent 50 µm.  The results are representative of the 
analysis of >3 mice each from control and CCKO groups.  C)  Quantification of Ki67(+) cells 
relative to total cells in control and CCKO samples from Fig. 3B.  Error bars represent standard 
deviation to the mean across samples from 3 mice of each genotype group. 
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were corroborated with immunofluorescence staining for Ki67, a marker for mitotic cells, of 5 
µm-thick sections excised from control and CCKO mammary glands.  At an earlier time point in  
lactation (lactation day 13), CCKO mammary glands showed only a modest increase in Ki67-
positive nuclei, compared to control glands (Figure 2.3B, top two panels).  However, at a later 
time point (lactation day 20), CCKO mammary glands continued to display mitotic activity, 
while control glands ceased proliferating as they entered into the early stage of involution, such 
that there was no appreciable Ki67 staining (Figure 2.3B, bottom two panels, and quantification 
in Figure 2.3C).   
We then analyzed the apoptotic activities of control and CCKO mammary glands, using 
cleaved caspase 3 as a read-out.  During lactation (i.e. lactation days 5 and 10), there was little or 
no difference in cleaved caspase 3 levels, when comparing lysates from control and CCKO 
mammary glands (Figure 2.3A).  However, at the end of lactation (L20), which is the early stage 
of involution, control glands showed an up-regulation of cleaved caspase 3 levels, whereas 
CCKO mammary glands did not (Figure 2.3A, third panel from top).  Taken together, these 
results indicate that the underdevelopment of the CCKO mammary glands is neither due to a 
reduction in cell proliferation nor to an increase in cellular apoptosis. 
Deletion of Cdc42 disrupts epithelial cell polarity in lactating mammary alveolar cells.  
We next examined whether the defects in mammary gland development exhibited by the 
CCKO mice were related to alterations in the epithelial structure of the alveoli.  At lactation day 
13, most alveolar epithelial cells in CCKO mammary glands had much lower levels of Cdc42 
expression, compared to control glands (Figure  2.4, red arrows in panels a and b).   
The deformation of epithelial structures in CCKO alveolar tissue (Figure 2.2, panels g and h) 
was more evident when cells were immuno-stained with the apical cell surface markers, Par6 and  
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Figure 2.4.  Cdc42 deletion disrupts apical/basal polarity in mammary alveolar epithelial 
cells. a,b: Immunohistochemistry images of 5 µm-thick sections from lactation day 13 depicting 
Cdc42 expression (brown) in alveolar luminal epithelial cells of the mammary gland from a 
control mouse (red arrow in a), as compared to a CCKO mouse (red arrow in b).  c,d: 
Immunohistochemistry images depicting the localization of Par6 at lactation day 13. Arrowhead 
in d indicates lipid accumulations. e,f: Immunofluorescence images showing the localization of 
aPKC (red) at lactation day 13.  Nuclei are stained blue.  g,h: Immunofluorescence images 
depicting laminin deposition (red) surrounding an alveolus from control and CCKO mammary 
glands.  Nuclei are stained blue.  Dashed lines outline representative alveoli.  “L” marks the 
central lumen of an alveolus.   Scale bars represent 50 µm.  The results are representative of the 
analysis of >3 mice each from control and CCKO groups. 
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atypical PKCζ (aPKCζ).  These two proteins form a complex with Cdc42 at the apical plasma 
membrane, controlling the establishment and maintenance of apical-basal cell polarity  
24).  In control mammary alveolar tissues, Par6 and aPKCζ were localized at the apical surface 
of the epithelial cells forming alveolar structures, as shown by immunohistochemistry and 
immunofluorescence images of 5 µm-thick sections (Figure 2.4, panels c and e, respectively).  
However, in CCKO mammary glands, the deformed epithelial cells exhibited only a partial 
apical membrane localization of Par6, whereas, aPKCζ lost its apical distribution and was 
diffusely distributed within the cell bodies (Figure 2.4, panels d and f, respectively). 
Since the de-regulation of Cdc42 has been shown to alter the composition of the 
extracellular matrix, as well as stromal-epithelial cell interactions in pre-pregnant mammary 
glands (16,25), we examined whether Cdc42 deletion in mammary alveolar cells affected 
extracellular basement membrane structures.  However, both control and CCKO alveolar tissues 
retained intact laminin deposition (Figure 2.4, panels g and h), and we did not detect significant 
alterations in the presence of myoepithelial cells, when comparing cytokeratin 14-
immunostaining between control and CCKO mammary alveoli (data not shown).  
Deletion of Cdc42 disrupts epithelial cell morphology in lactating mammary alveolar cells. 
We next examined cell-cell adhesion structures in control and CCKO lactating mammary 
alveolar tissues.  Immunofluorescence images revealed that control alveolar tissues at lactation 
day 13 expressed Cdc42 and E-cadherin, and that E-cadherin was localized at basolateral 
membranes and especially at the cell-cell contacts of epithelial cells (Figure  2.5A, panels a and 
c).  In CCKO alveolar tissues, Cdc42 deletion was accompanied by E-cadherin being diffusely 
dispersed within the cell bodies and no longer congregated at cell-cell contacts (Figure 2.5A,  
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Figure 2.5.  Epithelial identity changes in CCKO mammary alveolar epithelial cells.  A) 
Immunofluorescence staining (red) in 5 µm-thick sections from representative control and 
CCKO mammary alveoli at lactation day 13 depicting the expression and cellular localization of  
Cdc42 (a,b),  E-cadherin (c,d),  N-cadherin (e,f), and cytokeratin 8 (g,h). Nuclei are blue.  
Dashed lines outline representative alveoli.  “L” marks the central lumen of an alveolus.   Scale 
bars represent 50 µm.  The results are representative of the analysis of >3 mice each from control 
and CCKO groups.  B) Western blot of whole mammary gland tissue lysates probed for E-
cadherin, N-Cadherin, Snail, Twist, TGFβ1, phospho-SMAD 2/3, and cytokeratin 8 throughout 
lactation, with vinculin serving as a loading control. 
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Figure 2.5 
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panels b and d).  Collectively, these results suggest that Cdc42 is necessary for the maintenance 
of cell-cell adhesion as well as apical-basal cell polarity in established mammary epithelial cells, 
such that its loss leads to disorganized epithelial structures in mammary alveolar glands.   
E-cadherin expression was down-regulated in CCKO mammary glands, beginning as 
early as lactation day 5 and persisting throughout the entire lactation phase, accompanied by an 
increased expression of N-cadherin (Figure 2.5B).  This alternation in the cadherin expression 
profiles was observed in luminal mammary alveolar cells (Figure 2.5A, panels c - f).  An overall 
shift in the expression of E-cadherin to N-cadherin often indicates an epithelial to mesenchymal 
transition (EMT) (26-28).  We also found that TGFβ1 signaling through SMAD 2/3 appears to 
be increased in CCKO glands (Figure 2.5B).  However, the expression of Snail, which represses 
E-Cadherin expression and thereby promotes EMT in several tissues during development (26-28), 
was not changed in control versus CCKO glands, nor was Twist, another marker of EMT (Figure 
2.5B).  Thus, these findings suggest that a full EMT has not occurred.   
To identify the differentiation status of the cells comprising the CCKO mammary glands, 
we examined several markers for mammary epithelial cells by immunofluorescence and found 
that the expression of cytokeratin 8 (CK8) was up-regulated in CCKO alveoli throughout 
lactation, as compared to controls (Figure 2.5A, panels g and h, Figure 2.5B).  Importantly, 
although general epithelial structures were disrupted in CCKO glands, lipid accumulation and 
casein micelles were still apparent in CCKO glands (Figure 2.4, panel d, indicated by arrowhead), 
suggesting that the deformed epithelial cells retained the ability to produce milk. 
Deletion of Cdc42 causes premature cell exfoliation in lactating mammary alveoli. 
In the preceding sections, we showed that CCKO mammary glands failed to exhibit 
properly intact epithelial structures, leading to an abnormal alveolar architecture that contained 
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cells which were detached from the epithelial planes and found within the luminal cavities 
(Figure 2.2, panel h, indicated by arrowhead).  Studies performed using the 3D culture of 
primary mammary epithelial cells isolated from Cdc42flox/flox mice showed that the deletion of 
Cdc42 (via adenovirus-mediated Cre expression) in antecedently-formed mammary acini caused 
the epithelial cells to slough off or migrate into the alveolar lumen (indicated by an arrowhead, 
Figure 2.6).  This provided us with a clue regarding the reason for the apparent under-
development of the alveoli in CCKO mice (Figure 2.2), and led us to examine whether this 
phenotype was the result of the mammary alveolar epithelial cells sloughing off into the lumen 
and being removed by nursing pups.  To examine this possibility, we removed the nursing pups 
from control and CCKO mothers for five hours before harvesting the mammary glands at 
lactation day 19, thereby allowing any content within the mammary alveolar lumens to 
accumulate, instead of being removed from the ductal network and ingested by the nursing pups.  
Upon this treatment, CCKO mammary glands showed an accumulation of Cdc42-negative cells 
collected within the luminal cavities, while control glands did not (Figure 2.7).  
Immunofluorescence staining of serial sections showed that the Cdc42-negative cells, 
whether floating in the luminal space or still embedded within the alveoli in CCKO mammary 
glands, were indeed responsible for the up-regulated expression of CK8 (indicated by 
arrowheads, Figure 2.7, panels a - d).  The floating cells in the CCKO mammary glands did not 
show cleaved caspase 3-staining (indicated by arrowhead, Figure 2.7 panel f), suggesting that 
these cells were not removed from the epithelial planes due to apoptosis, which we occasionally 
detected within alveolar lumens in control mammary glands (Figure 2.7, panel e).  When 
combined with the findings from the preceding section, these results suggest that CCKO  
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Figure 2.6.  Cdc42 deletion causes luminal filling in primary mammary epithelial cells. 
Phase contrast images depicting primary mammary epithelial cells forming acini with hollowed 
lumens at the time of Adenovirus transduction (top panels).  Forty-eight hours after transduction, 
control (Ad-CMV-GFP) acini retain hollowed lumens (bottom left panel), while Cdc42-deletion 
(Ad-Cre-GFP) acini display cells that have migrated into the lumen (arrowhead, bottom right 
panel).   
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Figure 2.7.  Epithelial cell loss in CCKO mammary glands is due to premature sloughing.   
Immunofluorescence staining (red) in 5 µm-thick sections from representative control and 
CCKO mammary alveoli at lactation day 13, depicting the expression and cellular localization of 
Cdc42 (a,b), cytokeratin 8 (c,d) and cleaved caspase 3(e,f).  Arrowheads point to prematurely 
sloughed cells.  Nuclei are stained blue.  Dashed lines outline representative alveoli.  “L” marks 
the central lumen of an alveolus.  Scale bars represent 50 µm.  The results are representative of 
the analysis of >3 mice each from control and CCKO groups. 
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mammary alveolar cells lose their communication with neighboring cells, and thereby gain  
aberrant migratory capability. This results in their detachment from mammary epithelial planes, 
thereby resulting in an overall impairment in the development and function of CCKO mammary 
glands. 
DISCUSSION 
In this study, we have examined the roles played by Cdc42 in adult mammary gland 
function during lactation.  We show that the conditional deletion of Cdc42 results in a marked 
under-development of mammary alveoli, thus significantly impairing the ability of CCKO 
mothers to provide the proper nourishment to their pups.  This impairment in the development of 
lactating mammary alveoli is not caused by a reduction in cell proliferation nor through an 
increase in cellular apoptosis.  Rather, our studies show that CCKO mammary alveoli exhibit a 
latent and under-developed morphology because their alveolar cells prematurely exfoliate from 
epithelial planes during lactation, which is the result of structural defects and alterations in cell 
status caused by the deletion of Cdc42.   
At least some of the structural defects are likely the outcome of the inability of CCKO 
mammary alveolar epithelial cells to maintain proper cell polarity after the onset of lactogenesis. 
Indeed, the deletion of Cdc42 in pre-pregnant mammary epithelial cells has been reported to 
disrupt intact epithelial structures during acinar formation, due to defects in apical-basal cell 
polarity, cell-cell adherens structures, and tight junctions (17,18).  While Cdc42 has also been 
suggested to be important for establishing basement membrane structures by controlling stromal-
epithelial interactions, as well as for the deposition and processing of extracellular matrix 
proteins in pre-pregnant mammary glands (16,25), we did not detect any disruption of basement 
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membrane structures, nor histological differences in stromal layers, in lactating CCKO 
mammary alveoli.  
One of the most obvious changes accompanying Cdc42 deletion in mammary glands 
during lactogenesis was a marked reduction in E-cadherin expression at the whole gland-level, as 
well as the disruption of E-cadherin-dependent cell-cell adhesion structures.  At earlier lactation 
periods (lactation day 5), these changes were observed in a subset of the epithelial cell 
population within the mammary gland as the cells began to lose Cdc42 expression.  However, as 
lactation proceeded (lactation day 13), the diffuse localization of E-Cadherin was more readily 
apparent throughout the luminal alveolar epithelia.  We attribute this to the non-synchronous 
deletion of Cdc42 throughout the mammary gland at earlier time-points, leading to more 
thorough gene deletion as lactation proceeded.  While the changes observed at the earlier time 
periods were more subtle than those at later time points, even these subtle differences in the 
secretory capacity of the mammary gland can have a large effect on the newborn pups’ high 
demand for nutrients (29).  These data are consistent with reports implicating Cdc42 in the 
maintenance of E-cadherin homeostasis through its ability to promote the endocytosis and 
lysosomal degradation of non-trans-interacting E-cadherin, as mediated by the Par protein 
complex, WASP, and CIP4 (30,31), and by preventing trans-interacting E-cadherin from being 
endocytosed, as promoted by IQGAP1 (32,33).  Interestingly, the changes in E-cadherin levels 
observed in CCKO mammary alveoli were accompanied by a significant up-regulation of N-
cadherin expression.  This led us to examine whether the Cdc42 deletion promoted EMT, whose 
hallmark phenotype is the shift from the up-regulated expression of E-cadherin to N-cadherin 
(26-28).  However, while we did see elevated TGFβ1 signaling through SMAD 2/3, we did not 
detect the up-regulation of other marker proteins for EMT, including Snail and Twist (26-28).  
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Taken together, these data suggest that the deletion of Cdc42 caused a shift in mammary 
epithelial cell status, but did not induce EMT. 
As lactation proceeded, CCKO mammary alveolar cells also exhibited a striking up-
regulation of CK8, which has been shown to be expressed in the mammary ductal epithelial cells 
of virgin female mice, but absent in luminal epithelial cells of the lactating mouse mammary 
gland (34).  Since the alterations in cell status occurred over an extended period of time 
following the deletion of Cdc42, these changes might be indirect effects caused by Cdc42 
deletion.  Apparently, the epithelial cell morphology of mammary alveolar cells, as controlled by 
Cdc42, has an essential role in maintaining their cell identity.  Considering that both N-cadherin 
and CK8 are suggested to be up-regulated in invasive breast cancer (35,36), CCKO mammary 
alveolar cells, upon losing cell-to-cell contacts and proper tissue architecture, might acquire a 
shift in epithelial cell identity.  This may also explain the ability of the alveolar cells to exfoliate 
and undergo a premature sloughing off into the lumens.    
The lactating CCKO mammary glands exhibited sustained cell proliferation even within 
the time window when control glands were undergoing the beginning stages of involution 
(lactation day 20).  We also observed a sustained activation of STAT5, which is a key regulator 
of maturation and cell proliferation in mammary alveologenesis.  However, studies using the in 
vitro 3D cell culture model have shown that the introduction of the dominant-negative 
Cdc42(T17N) mutant into established acini did not affect the prolactin-induced phosphorylation 
of STAT5 (18).  Collectively, these results would suggest that it is unlikely Cdc42 directly 
regulates prolactin-dependent STAT5 activation.  Instead, the loss of Cdc42 may give rise to an 
overall delay in the steps that control the balance between the cessation of cell proliferation and 
the onset of programmed cell death necessary for proper adult mammary gland function.  Indeed, 
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we found the levels of activated caspase-3 to be significantly reduced at lactation day 20 in 
CCKO mammary glands, compared to controls.  
Structural deformities in the CCKO mammary tissue might also explain some of the 
phenotypes accompanying Cdc42 deletion.  In the normal development of the mammary gland 
after weaning, continued milk production increases intra-mammary pressure, which inhibits the 
secretion of hormones promoting milk production, while inducing the secretion of hormones 
promoting involution (15).  Since CCKO mammary glands are under-developed and lose the 
cell-cell barriers that normally maintain intra-mammary pressure, CCKO mammary glands might 
fail to secrete hormones that promote involution. 
We also analyzed global gene expression changes between the control and CCKO mice at 
lactation day 5, by using RNA Seq analysis.  Of 23,352 genes and 30,608 transcripts analyzed, 
only 67 genes and 57 transcripts were found to be differentially expressed with significance 
between the two samples (data not shown).  These differentially-expressed genes mapped mostly 
to stress response biological programs, as evaluated using iPathway Guide software, which might 
be an indirect consequence of the abnormal epithelial cell status and premature sloughing of cells 
in CCKO mammary glands.   
In conclusion, our work and that of others suggest that the physiological functions of 
Cdc42 can be quite diverse and specific to different cell types and stages of development (16-
18,25). Here we have shown that the loss of Cdc42 and the inability of CCKO cells to establish 
proper cell polarity and cell-cell contacts have severe consequences for the functioning of adult 
mammary glands.  Certainly, an important question for the future concerns how the 
physiological functions of Cdc42 in normal mammary cells correspond to its aberrant behavior 
in some forms of breast cancer, in which it is over-expressed (37).  This could give rise to de-
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regulated Cdc42-signaling activities that interfere with the establishment or maintenance of 
proper cell polarity.  Thus, it is easy to imagine how on the one hand, the impact of altered 
mammary cell polarity and glandular structure that accompanies the loss or de-regulation of 
Cdc42 can result in improper mammary gland function and lactogenesis, while on the other hand, 
the over-expression of Cdc42 and its excessive signaling disrupts normal cell polarity and 
contributes to the transformed state and the malignant phenotypes that accompany breast cancer 
progression.  A better understanding of these Cdc42 functions during the development of 
different forms of breast cancer could lead to new strategies regarding how and when to target 
Cdc42-signaling events as possible anti-cancer therapies. 
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Chapter 3 
The Effects of Constitutively Active Cdc42 on Mammary Alveolar Morphogenesis and 
Maintenance 
 
 
Abstract 
 Cdc42 overexpression and hyperactivity are found in certain human ductal carcinomas of 
the breast, and a constitutively-active activator of Cdc42, onco-Dbl, confers characteristics of 
cancer onto normal fibroblast cells, bringing to question the role of this small GTPase during 
human breast carcinogenesis.  The conditional knockout of Cdc42 in the adult mouse mammary 
gland results in abnormal epithelial organization due to altered cell polarity and cell-cell contacts, 
traits that are also altered in breast cancer progression.  These data suggest a critical role for proper 
Cdc42 signaling in mammary epithelial cell function and maintenance.  Here, we have examined 
the actions of the hyperactive mutant Cdc42[F28L] in primary mammary epithelial cells (MECs) 
cultured in both monolayer and 3D conditions.  Primary MECs expressing Cdc42[F28L] in 
monolayer growth caused actin-based stress fiber formation and multi-nucleated cells, while in 3D 
culture Cdc42[F28L] induced luminal filling and invasive traits in the cells.  Further analysis 
showed that Cdc42[F28L] required binding to IQGAP1 to cause the MECs to acquire invasiveness, 
but not luminal filling.  These findings suggest that aberrant Cdc42 signaling can contribute to 
multiple aspects of breast cancer progression, including the loss of alveolar luminal architecture 
and the acquisition of invasive characteristics, and that these traits are due to specific effector 
binding.   
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Introduction 
 Breast cancer research has developed into an enormous field, utilizing an impressive 
variety of techniques to further our understanding of carcinogenesis.  With studies ranging from 
mammary stem cell biology to cancer cell metabolism and physiological metastasis, our 
knowledge base continues to grow as we seek more effective breast cancer therapies.  Current 
long-term breast cancer therapy continues to rely on both the ability to prevent further breast 
tumors from forming after the original tumor is detected, as well as preventing metastasis to other 
tissues within the patient.  However, challenges remain for some breast cancer survivors even after 
primary tumor excision, as residual cancer cells that are undetected within the breast may still have 
the potential to form new tumors.  Adding to these challenges, the original excised tumor may 
have already spread to new sites of growth in the patient’s tissues before the primary tumor was 
removed from the patient (1).  This latter threat is particularly relevant to advanced, stage IV-type 
breast cancers and has brought a focus to the study of cancer cell metastasis, with the hope of 
designing therapies that could prevent breast cancer cells from escaping the mammary gland 
environment and metastasizing to new tissues (commonly bones, lungs, liver or brain) within the 
patient.  
 The likelihood that a cancer cell will metastasize is largely dependent on its ability to 
migrate and invade (2, 3).  Neighboring epithelial and stromal cells, as well as extracellular 
matrices that have been distributed throughout the tissue, typically help to ensure that cells migrate 
minimally in adult tissues, and only when temporally required, such as during wound healing (4).  
Invasive cancer cells are able to overcome the migration-retarding signals provided by the 
extracellular environment in tissues, in part by displaying traits similar to an epithelial to 
mesenchymal transition (EMT) (5–7), which is a plasticity developed by epithelial cells that is 
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critically important during embryogenesis and wound healing.  The down-regulation of proteins 
that confer epithelial cell characteristics (such as E-cadherin), and the up-regulation of proteins 
that elicit the features of mesenchymal cells (including N-cadherin expression and the release of 
matrix metalloproteinases) are part of the functional shift required to induce an epithelial cell to 
acquire the phenotypic properties of a mesenchymal cell.  This change in gene expression allows 
epithelial cells, which are apical-basal polarized and adjoined to neighboring epithelia via adherens 
junctions, to dissolve these cell-to-cell junctions and establish front-rear polarity, allowing for the 
mesenchymal cell characteristics necessary for migration.  Once the correct extracellular 
environment is found, the mesenchymal cell can transition back into an epithelial cell by the 
reverse process, termed a mesenchymal to epithelial transition (MET).  This cellular plasticity is 
critical to the development and function of higher life-forms, yet when acquired by cancer cells, 
an EMT can turn benign tumor cells into metastatic assassins of their host.  For this reason, great 
efforts have been invested in research toward understanding the shift from an epithelial-like to a 
mesenchymal-like phenotype, with particular focus on the mesenchymal attributes of invasive 
migration.   
 While some of the hallmarks of cancer, such as cell growth in the absence of mitogenic 
signals and the evasion of programmed cell death, can be studied under monolayer cell culture 
conditions, the investigation of invasive migration requires a model system that can analyze the 
ability of cells to invade through an environment composed of multiple cell types and extracellular 
matrix.  To this end, transwell-migration assays have provided a means to study cell migration 
through an extracellular matrix analog, yet questions of the physiological relevance of this assay 
still remain (8, 9).  Along with this, cells that are grown in monolayer culture conditions are 
disconnected from their native tissue environmental cues and therefore lose the ability to 
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recapitulate their physiological control over migration, proliferation, metabolism, differentiation, 
and death.  In response to this challenge, the use of primary epithelial cells cultured in three-
dimensional (3D) growth systems has been developed to provide a means of more closely 
mimicking an in vivo environment in which to study complex cellular biology, including processes 
like invasive migration (10, 11).  Studies using mammary epithelial cells (MECs) that are grown 
in 3D conditions have elegantly illustrated the differences in oncogenic signals that lead either to 
luminal filling (a condition similar to ductal carcinoma in-situ) or to invasive characteristics that 
are comparable to invasive ductal carcinoma (12) .  As such, this system has provided a valuable 
method for examining different stages of breast cancer progression, offering researchers a useful 
bridge between studies performed in monolayer cell culture and those done in an in vivo model. 
 The Rho-family GTPase Cdc42 has been shown to affect multiple cell signaling cascades, 
resulting in an array of potential downstream cellular effects and biological outcomes (13–15).  In 
reviewing the diversity of effects that can result from altered Cdc42 function, it becomes apparent 
that the specific Cdc42 signaling outputs that occur are dependent upon the cellular context.  This 
makes it challenging to translate the different Cdc42 functions observed in cell culture models 
with those that have been identified from studies performed in physiologically-relevant settings, 
as the varying cell types within our tissues may rely on Cdc42 in different ways.  As an example, 
studies of Cdc42 using fibroblasts grown in monolayer conditions showed that a constitutively-
active Cdc42 mutant induced the formation of stress fibers and actin-rich microspikes at the cell 
periphery (16, 17), but how these functions relate to the embryonic lethality accompanying the 
deletion of Cdc42 in the mouse (18) is unclear.  Therefore, the ability to accurately identify cell 
signaling pathways that are influenced by Cdc42, while also describing its physiological roles, 
requires a perspective that can integrate the results from cell culture model systems with those 
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obtained from in vivo studies in animal models.  To this end, the culture of primary epithelial cells 
in both monolayer and 3D culture systems offers the possibility for providing important insights 
into cell signaling events that occur within a physiological setting.   
 A study using primary Cdc42 flox/flox MECs that were isolated from the mouse, infected 
with AdenoCre-virus, and then plated in either monolayer or 3D culture conditions, showed that 
the functional consequences of Cdc42 expression on MEC function varies between these two 
conditions (19).  Primary MECs grown in monolayer conditions exhibited no detectable changes 
in cell cycle control in the presence or absence of Cdc42 expression, yet primary MECs lacking 
Cdc42 grown in 3D culture showed drastically reduced proliferation and survival rates.  These 
findings highlight the complexity of Cdc42 signaling, not only in a cell-type dependent manner 
but also in the context of the extracellular environment.  It was only in the context of the apical-
basal polarity that is established within mammary alveoli that Cdc42 was shown to regulate cell-
cycle control in primary MECs.  As breast cancer cells commonly lose their ability to properly 
respond to their extracellular environment (20), understanding how normal mammary epithelial 
cells respond to key signaling proteins like Cdc42 becomes essential to furthering our knowledge 
of the progression of this disease. 
 Cdc42[F28L], a constitutively-active mutant, has been shown to confer cancer-like 
characteristics, such as anchorage-independent growth and growth in low serum, to non-
transformed NIH 3T3 fibroblasts in monolayer cell culture conditions (21).  As these data were 
obtained in monolayer growth conditions on immortalized cells, I wanted to determine how 
Cdc42[F28L] influences primary mammary epithelial cells grown under conditions more similar 
to their native tissue environment.  To address this, I have isolated primary MECs from adult 
female mice and introduced the expression of Cd42[F28L] during their growth in either monolayer 
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or 3D conditions.  These two growth conditions instruct the epithelia differently, and may also 
affect how cells interpret the signaling outputs of Cdc42[F28L].  Indeed, I anticipate that by 
comparing these different cell culture systems, important insights may be gained into the roles of 
Cdc42 during breast cancer progression.  
Experimental Procedures 
 Primary mammary epithelial cell (MEC) isolation and culture- The fourth pair of 
mammary glands were harvested from euthanized twelve-week-old virgin Cdc42flox/flox female 
mice.  Similar to the procedure described in Chapter Two, and following the protocol from Lo et 
al (22), the mammary glands were minced for two minutes using two sterile razor blades pressed 
together, and then digested at 37° C with 100 rpm rotation in digestion buffer (2 g/l trypsin 
(Invitrogen), 2 g/l collagenase type-iv (Invitrogen), 5% v/v FBS (Invitrogen), and 5 µg/ml insulin 
(Sigma) in DMEM/F12 medium (Invitrogen)).  Digested mammary glands were then centrifuged 
at 400 g for 15 minutes at room temperature.  From this, the top 15 ml of fat cell-containing media 
was removed and resuspended in DMEM/F12, and then centrifuged again at 400 g for 15 minutes 
at room temperature, along with the original resuspended pellet of organoids.  The resulting pellets 
were then resuspended and combined in DMEM/F12 and centrifuged at 400 g for 15 minutes at 
room temperature.  This pellet was resuspended in DMEM/F12 containing 2 U/µl DNase 1 (Sigma) 
for 5 minutes at 37 ° C with gentle swirling.  To remove the DNase 1, the suspension was 
centrifuged at 400 g for 15 minutes at room temperature, after which the pellet was resuspended 
in DMEM/F12 and pulse-centrifuged twice at 260 g at room temperature to enrich for epithelial 
cells and remove fibroblasts.  The epithelial-rich pellet was resuspended in DMEM/F12 containing 
1x Insulin-Transferrin-Sodium Selenite (ITS, Sigma) and 1x Penicillin/Streptomycin (PS, 
Invitrogen), and organoids were then counted and plated accordingly. 
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 Primary MEC culture and Cdc42 mutant expression- After isolation, Lentivirus containing 
Cdc42[F28L] or the Cdc42[F28L:F37A] mutant was then added to the organoid suspension at an 
MOI of approximately 40.  These solutions were then spinoculated by centrifugation using 1000g 
for 20 minutes to enhance viral entry into the cells, after which the pelleted organoids were either 
resuspended in Growth Factor Reduced Matrigel (Corning) and plated in 8-well chamber slides at 
approximately 200 organoids per well, or alternatively plated for monolayer growth on 60mm cell 
culture dishes at a concentration of approximately 200 organoids per dish.  After the isolation and 
suspension of primary organoids in Growth Factor Reduced Matrigel, DMEM/F12/ITS/PS (300 
µl) were added to the top of the matrigel, and the organoids were cultured at 37° C and 5% CO2 in 
an incubator overnight.  After 24 hours, the media was exchanged with DMEM/F12/ITS/PS 
containing 9 nM TGFɑ (Sigma). After 6 days of 3D culture, exchanging the 
DMEM/F12/ITS/PS/TGFɑ media every second day, control organoids formed hollowed alveoli.  
For the monolayer growth treatment, organoids were plated on 60mm dishes after harvest and 
isolation, and supplemented with 1mL of DMEM/F12/ITS/PS.  This medium was removed by 
aspiration after 24 hours, and replaced with DMEM/F12/ITS/PS containing 9 nM TGFɑ (Sigma).   
DMEM/F12/ITS/PS medium containing 9 nM TGFɑ was then exchanged every two days for the 
remainder of the experiments.  For some experiments, Lentivirus was added to the media:  control 
cultures were given an HA-tag virus at an MOI of approximately 80, while experimental cultures 
were given Cdc42[F28L] or Cdc42[F28L,F37A] virus at an approximate MOI of 80.  Cells were 
imaged on an Olympus CK2 inverted microscope with an Olympus Camedia C-5050 digital 
camera, with samples presented representing the majority of phenotypes found. 
 Immunofluorescence staining and imaging- Primary MECs grown in monolayer culture 
were removed from incubation and all media was aspirated from the 60mm culture dishes.  Cells 
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were then fixed in 4% PFA (dissolved in PBS) for 15 minutes at room temperature.  The 4% PFA 
solution was then aspirated from the 60mm dishes, and the cells were given 3 PBS washes of 5 
minutes each, followed by blocking for one hour in 10% Bovine Serum Albumin (BSA)/PBS at 
room temperature.  After removing the blocking solution, primary antibodies were diluted in 10% 
Bovine Serum Albumin/PBS and added to the cells to incubate overnight at 4° C.  Primary 
antibody dilutions were then aspirated from each dish of cells, and the cells were treated with 5 
PBS washes of 5 minutes each, followed by a 30 minute incubation of Secondary AlexaFluor 594-
conjugated antibodies (Sigma), which were diluted 1:300 in 10% BSA.  Cells were then rinsed 
again in 5 PBS washes of 5 minutes each, with the third wash containing 4,6-diaminodino-2-
phenylindole (Sigma Aldrich) at a 1:10000 dilution.  The samples were then coverslipped and 
sealed using KPL Fluorescent Mounting Media. 
 Primary MECs grown in 3D culture were removed from incubation, and all media was 
aspirated from the top of the chambers.  The cultures of cells were then fixed by the addition into 
each chamber of a 1:1 acetone/methanol solution for 30 minutes at room temperature, after which 
the fixing solution was aspirated.  Chamberslides were then disassembled, and primary MECs, 
while still embedded within Matrigel, were thinly spread across VWR Permafrost glass slides 
using a p1000 tip and placed on a covered slide warmer for 60 minutes at room temperature.  Slides 
were then placed in 3 PBS washes of 20 minutes each, after which they were immersed in a 10% 
BSA/PBS blocking solution at 4° C overnight.  Slides were then placed into 50mL Coplin jars 
containing the primary antibodies diluted in PBS.  The slides were incubated in primary antibodies 
overnight at 4° C, after which they were rinsed in 5 PBS washes of 20 minutes each.  Secondary 
AlexaFluor 594-conjugated antibodies (Sigma) were then diluted 1:300 in PBS, and the slides 
incubated in this solution for one hour at room temperature.  Samples were then rinsed at room 
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temperature in 3 PBS washes of 20 minutes each, and then counterstained with 4,6-diaminodino-
2-phenylindole (Sigma Aldrich) at a 1:10000 dilution in double distilled water (ddH2O) for 10 
minutes.  Samples were then rinsed in 3 PBS washes of 20 minutes each, and then coverslipped 
and sealed using KPL Fluorescent Mounting Media. 
 Epifluorescence imaging for both the monolayer and 3D culture conditions was performed 
on a Zeiss inverted Axioskop equipped with a COOKE Axiocam/Sensicam camera. 
 Antibodies- Antibodies used for immunofluorescence were purchased from the following 
companies: anti-IQGAP1 (ab133490) and anti-Ki67 (ab15580) antibodies were obtained from 
Abcam Inc; E-Cadherin (CS3195) and anti-pan-actin (CS8456) antibodies were from Cell 
Signaling Technology; anti-laminin antibody (AB1953) was from Chemicon International (now 
EMD Millipore).  
Results 
Comparing the effects of a constitutively active Cdc42 mutant in primary mouse mammary 
epithelial cells (MECs) cultured in monolayer and three-dimensional systems. 
In Chapter 2, Cdc42 was shown to play critical roles in the maintenance of apical-basal 
cell polarity and cell-cell sensing in the adult mouse mammary gland.  These results raised new 
questions about how the roles in normal adult mammary tissue relate to the actions of Cdc42 in 
breast cancer.  To begin to address these questions, I used the method of primary MEC isolation 
and culture described in Chapter 2 to obtain Cdc42 flox/flox MECs.  However, instead of analyzing 
the roles played by Cdc42 in the function of MECs and their morphogenesis into alveoli using a 
loss-of-function approach, in this study I examined the effects of introducing into primary MECs 
a Cdc42[F28L] mutant, which our laboratory has previously shown to be capable of constitutive 
GDP-GTP exchange (termed a “fast-cycling” mutant) and of conferring cancer-like growth 
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characteristics upon NIH 3T3 fibroblasts (21).  The use of a monolayer culture system made it 
possible to examine the effects of Cdc42[F28L] on cell migration, focal adhesion formation and 
cell division, whereas the 3D culture system enabled us to examine the effects of fast-cycling 
Cdc42 on mammary alveolar morphogenesis processes.  These 3D alveolar morphogenesis 
processes include cell migration and division, but also encompass cell differentiation and apical-
basal polarity, as well as growth inhibition even in the presence of growth factor stimulation.  The 
comparison of the effects of Cdc42[F28L] in these two model systems can highlight the unique 
roles played by Cdc42 in cell signaling within the context of the extracellular environment, which 
is highly relevant and carries a great deal of interest in the study of breast cancer progression.  
 To perform these experiments, organoids rich with primary MECs were isolated from 
mouse mammary glands and then either plated on cell culture dishes for monolayer growth, or 
embedded in growth factor-reduced Matrigel for 3D growth.  These cultures were then 
supplemented with TGFɑ to promote EGFR activity and mitogenic signaling pathways within the 
MECs (Figure 3.1).   Twenty-four hours after plating the organoids in either condition, the MECs 
appeared similar using phase microscopy (Figure 3.2, compare panels a and b), except that some 
of the cells plated in the monolayer condition were attaching to the culture dish and migrating 
away from the plated organoid (red arrowheads in Figure 3.2, panel a).  After seven days of TGFɑ-
stimulated growth, MECs growing in monolayer conditions were observed to be dividing and 
migrating even further onto the culture dish (white arrowheads in Figure 3.2, panel c), while the 
MECs embedded within the 3D matrix underwent a different type of growth, as they formed 
hollowed alveolar structures through a process of morphogenesis (Figure 3.2, panel d).  The MECs 
that formed these alveoli in 3D culture displayed an organization similar to that found in mammary  
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Figure 3.1.  Analyzing the Effects of Constitutively-Active Cdc42 Using Monolayer and 
Three-Dimensional (3D) Primary Cell Culture Systems.  Schematic diagram describing the 
strategy used to culture primary mammary epithelial cells (MECs) in either a monolayer or 3D 
system.  After isolation from mouse mammary glands, MECs plated on culture dishes grow in a 
monolayer fashion, migrating and dividing in the presence of medium containing TGFɑ, while 
MECs embedded in growth-factor-reduced Matrigel undergo morphogenesis into 3D alveoli in the 
presence of the same medium.  Constitutively-active Cdc42 mutants or an empty vector (control) 
were expressed in the primary MECs growing in either condition using lentivirus infection. 
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Figure 3.1 
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Figure 3.2.  Primary MECs Display Growth Characteristics Dependent on their Culture 
Conditions. Phase contrast images depicting primary MEC organoids 24 hours after plating in 
either monolayer or 3D culture conditions.  a,b:  MECs plated in monolayer conditions are shown 
attaching to the culture dish and migrating near the bottom of the isolated organoid (red arrowheads 
in panel a), while MECs plated in the 3D culture system appeared as solid organoids within the 
Matrigel (panel b).  c,d:  After 7 days of growth, primary MECs display distinct characteristics in 
either monolayer or 3D culture conditions.  MECs grown in monolayer conditions attached to the 
culture dish, and displayed flattened morphologies as they migrated onto the substratum (panel c).  
MECs grown in 3D conditions formed hollowed, spherical alveoli, and established an inner lumen 
(asterisk in panel d) lined by the apical surface of polarized cells (red arrowheads in panel d).  e,f:  
After 7 days of growth, mitotically-active cells were labeled with Ki67 (red) and nuclei were 
counterstained blue.  Many mitotically-active primary MECs were observed in monolayer culture, 
while few were observed 3D culture (white arrowheads in panels e,f).   
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Figure 3.2 
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gland tissues, where apical-basal cell polarity allows for the formation of an alveolar epithelial cell 
lining (red arrowheads in Figure 3.2, panel d) that performs a barrier-like function surrounding a 
hollowed lumenal space (asterisk in Figure 3.2, panel d).   
 The MECs that were cultured in monolayer conditions and migrating out onto the culture 
dish became mitotically-active, as indicated by the expression of Ki67 (white arrowheads in Figure 
3.2, panel e).  However, the MECs cultured in 3D conditions formed alveolar structures that 
reached a certain size and then largely remained growth-arrested, even when continually 
supplemented with growth-factor medium (white arrowhead in Figure 3.2, panel f), and survived  
for at least several months.  The MECs grown in 3D culture can be compared to the MECs that 
comprise the alveolar units in the adult virgin mouse mammary gland, which have undergone some 
growth to propel morphogenesis, but then remain growth-arrested and “awaiting” the potential 
hormonal cues of pregnancy (23).  The monolayer conditions did not provide the cues to allow the 
MECs to attain this cell differentiation status and, as such, they continued to migrate and divide 
until their death, which was within a month after their isolation from the mouse mammary glands.  
These different cell culture environments represent a window through which to view cell signaling 
in the presence or absence of morphogenesis-related cues for cellular growth control.  
Fast-cycling Cdc42 signals to IQGAP1 to cause alveolar luminal filling and MEC invasion into 
the extra-alveolar environment.  
 As Cdc42[F28L] had previously been examined in NIH 3T3 fibroblasts grown in 
monolayer conditions, I was curious to see not only if this mutant would have similar effects on 
primary MECs growing in monolayer conditions, but also if fast-cycling Cdc42 would have any 
effects on the growth-arrested, apical-basal polarized MECs grown in 3D conditions.  To address 
these questions, I used an epitope HA-tagged lentiviral system to express Cdc42[F28L] in primary 
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MECs grown in both monolayer and 3D culture conditions.  Expression of Cdc42[F28L] in MECs 
could be visualized by immunofluorescence staining for HA (Figure 3.3).  Monolayer cultures of 
MECs expressing Cdc42[F28L] displayed similar characteristics to those previously observed in 
NIH 3T3 fibroblasts (21), with actin-based stress fiber formation visible in the sprawling cells, 
many of which were multi-nucleated (Figure 3.4).  These data suggested that the actions of 
Cdc42[F28L] are indeed similar between primary MECs and NIH 3T3 fibroblasts when the cells 
are cultured in monolayer conditions. 
 The expression of Cdc42[F28L] in MECs that had antecedently formed growth-arrested 
alveoli with hollowed central lumens in 3D culture commonly caused the MECs to fill this 
hollowed alveolar lumen, whereas expression of an empty control vector did not (Figure 3.5, 
compare panels a and b).  Interestingly, Cdc42[F28L] also appeared to cause cell invasion into the 
Matrigel surrounding the alveoli (red arrowhead in Figure 3.5, panel b).  Given that Cdc42 played 
a major role in E-Cadherin stabilization, presumably through IQGAP1, at adherens junctions in 
Chapter 2 (Druso, et al. 2016), and that Cdc42, IQGAP1, and Clip170 have been shown to capture 
and bundle microtubule (+) ends at the leading edges of migrating cells (24), I was interested in 
seeing whether the interaction between Cdc42[F28L] and IQGAP1 in mouse MECs played an 
important role in the results observed in 3D cell culture.  Thus, I expressed a Cdc42[F28L,F37A] 
mutant, which is constitutively active but was previously shown by our laboratory to be defective 
in binding to IQGAP1, in the MECs grown in 3D culture.  Interestingly, this Cdc42 mutant caused 
the luminal filling phenotype in the alveolar buds, but did not appear to cause MECs to invade into 
the surrounding Matrigel (Figure 3.5, panel c).  As these data collectively suggest IQGAP1 as a 
critical binding partner of Cdc42 in MEC function, I next examined the sub-cellular localization 
of IQGAP1 in the MECs grown in 3D culture.   
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Figure 3.3.  Expression of HA-tagged Cdc42[F28L] Visualized by Immunofluorescence.  
Immunofluorescence staining of primary MECs grown in 3D conditions displaying the expression 
of an HA-tagged Cdc42[F28L] vector delivered by lentivirus. 
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Figure 3.3 
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Figure 3.4.  Constitutively-Active Cdc42 Induces Actin-Based Stress Fiber Formation and 
multi-nucleated cells in Primary MECs Cultured in Monolayer Conditions.  Upper image 
shows immunofluorescence co-staining for pan-actin and DAPI in primary MECs expressing 
constitutively-active Cdc42[F28L].  MECs under this condition commonly displayed stress fiber 
formation and multi-nucleation similar to that seen in NIH 3T3 fibroblasts expressing 
Cdc42[F28L].   Lower image depicts schematic diagram for MECs cultured in monolayer 
conditions. 
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Figure 3.5.  Constitutively-Active Cdc42 Causes Alveolar Luminal Filling and Invasion in an 
IQGAP1-dependent Manner in Primary MECs Cultured in 3D Conditions.  Upper panels 
show phase contrast images depicting a hollowed alveolus formed by MECs expressing a control 
vector (panel a), a filled alveolus with cellular invasion into the surrounding Matrigel in MECs 
expressing constitutively-active Cdc42[F28L] (panel b, red arrowhead indicates invading cells), 
and a filled alveolus that does not display cellular invasion in MECs expressing constitutively-
active Cdc42[F28L,F37A], which is defective in binding IQGAP1 (panel c).  Lower image depicts 
schematic diagram for MECs cultured in 3D conditions.   
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102 
 
 Immunofluorescence staining of the alveolar buds grown in Matrigel showed that IQGAP1 
localized to the cell-cell junctions in the mature, growth-arrested alveoli expressing a control 
vector (Figure 3.6, top panels).  Similar to the case for the mouse mammary gland in vivo, these 
MECs also formed a laminin-rich extracellular matrix that encapsulated the alveolus and allowed 
the cells to attain their apical-basal polarity (Figure 3.6, bottom panels).  However, within the 
alveoli in which Cdc42[F28L] was expressed, the localization of IQGAP1 became diffuse and was 
detected at early time-points (48 hours) in filopodia-like projections at the periphery of the alveolus 
(Figure 3.7, top left and middle panels).  These IQGAP1-rich projections appeared to be 
invadopodia, which are formed by invasive cells and can break down the laminin-rich extracellular 
matrix that forms around the alveolus, allowing for cell dispersal into the surrounding stroma (2, 
25).  In this model system, the invadopodia represent a critical step in breast cancer progression in 
which abnormal, dysfunctional MECs begin to invade into their surrounding tissue and ultimately 
metastasize.  Over time (96 hours), these invadopodia led to long extensions of cells invading into 
the surrounding Matrigel, with the tips of these invading cell protrusions being rich in IQGAP1 
(white arrowhead in Figure 3.7, top right panel).  Cdc42[F28L] was capable of causing this 
remarkable type of invasive behavior in the MECs grown in 3D culture, but only when it was able 
to signal to IQGAP1.   
Fast-cycling Cdc42 disrupts E-Cadherin localization at adherens junctions and leads to its down-
regulation in invading MECs. 
 The findings described in Chapter 2, together with the effects of Cdc42[F28L] on primary 
MECs grown in 3D culture, illustrate the significance of the role of Cdc42 binding to IQGAP1 in 
the mammary gland.  Given the array of potential effects that Cdc42 signaling can have in different  
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Figure 3.6.  IQGAP1 is Localized to Cell-Cell Contacts in Primary MECs Grown in 3D 
Conditions, and 3D Alveoli Are Encapsulated by a Laminin-Rich Matrix.  Upper panels 
display immunofluorescence staining for IQGAP1 (red) in primary MECs grown in 3D conditions 
(nuclei in blue).  IQGAP1 can be seen at cell-cell contacts in the formed alveoli.  Lower panels 
display immunofluorescence staining for the mouse mammary gland basement membrane matrix 
protein laminin (red), which encapsulated each alveolus (nuclei in blue). 
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Figure 3.7.  Constitutively-Active Cdc42 [F28L] Causes IQGAP1-rich Invadopodia, Cellular 
Invasion and Reduced E-cadherin Expression in MECs grown in 3D Culture.  Upper panels 
display IQGAP1 (red) enrichment in invadopodia (upper left panel and white arrowhead in middle 
panel) that lead to cellular invasion away from the alveolus (white arrowhead in upper right panel).  
Lower panels display E-cadherin (red) localization at cell-cell contacts in MECs expressing control 
vector (white arrowheads in lower left panel), and the loss of E-cadherin expression in MECs 
expressing constitutively-active Cdc42[F28L] that have invaded the surrounding Matrigel (white 
arrowheads in lower right panel).  Cell nuclei are blue. 
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cell types (15, 26), these data collectively suggest that the functional plasticity found in MECs  
from the mammary gland relies, at least in part, on Cdc42.  To further investigate the link between 
Cdc42[F28L] signaling through IQGAP1, and the shift of MECs to an invasive phenotype, I next 
examined the E-cadherin-based contacts formed between the cells comprising the alveoli.  Similar 
to the localization of IQGAP1 in the control MECs (Figure 3.6), E-cadherin was also found at the 
cell-cell contact points throughout the control alveoli (white arrowheads in Figure 3.7, bottom left 
panel).  In the presence of Cdc42[F28L] expression, however, E-cadherin localization became 
diffuse within the MECs, again like IQGAP1, but with one striking difference.  The IQGAP1-rich 
MECs that were seen invading out from the alveoli and into the surrounding extracellular matrix 
could also be visualized using a nuclear stain in this experiment, but further immunofluorescence 
staining showed that these invading cells did not express E-cadherin (white arrowheads in Figure 
7, bottom right panel).   
 Taken together, these data suggest that Cdc42[F28L] is capable of altering the localization 
and stability of E-cadherin in primary MECs, as well as causing the cells to transition into an 
invasive phenotype.  IQGAP1 appears to be an important effector through which this invasive 
phenotype is accomplished, suggesting that the previously shown mechanism of Cdc42-mediated 
capture of microtubules via IQGAP1 and Clip 170 (24) is present in primary mouse MECs, and 
may contribute to the progression of breast tumors from ductal carcinoma in-situ (DCIS) to 
invasive ductal carcinoma.     
Discussion 
 In this study, I have examined the effects of aberrant Cdc42 signaling on primary MECs 
using two methods of cell culture.  While a significant understanding of Cdc42 signaling has been 
obtained using monolayer cell culture systems, the advancement of 3D cell culture studies has 
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highlighted the important influence imparted by the extracellular environment and cell-to-cell 
communication on the cellular responses to mitogenic, and even oncogenic, signaling (27).  With 
this in mind, I set out in the present study to investigate the differences in effects caused by 
overactive Cdc42 signaling in mammary epithelial cells grown in monolayer versus 3D culture.   
 I found important differences in MEC growth and survival between the two culture 
systems, in which the 3D condition provided morphogenesis cues to instruct the MECs to grow 
and organize into hollowed alveoli, whereas the monolayer condition caused the MECs to divide 
and migrate onto the culture dish in the absence of the cues that are provided by the tissue 
extracellular environment.  Interestingly, together with these differences was a shortened survival 
of the MECs grown in monolayer conditions as compared to those grown in 3D conditions.  Under 
monolayer growth conditions, the primary MECs divided and migrated, albeit at a slower rate 
compared to common immortalized cell lines, until their death at about three weeks post-plating.  
MECs cultured in the 3D condition did not undergo cell death after three weeks of culture, but 
instead grew into hollowed alveoli connected by ductal structures that remained viable during my 
observation period of three months post-plating.  This difference suggests that the establishment 
of the 3D alveoli, accompanied by the formation of MEC apical/basal polarity and cell-to-cell 
junctions, provided a survival advantage to the cells.   
 Next, I investigated the potential differences in the effects triggered by a constitutively-
active Cdc42 mutant, Cdc42[F28L], in MECs growing under these two cell culture conditions.  
Cdc42[F28L] conferred characteristics of cancer transformation onto primary MECs grown in both 
the monolayer and 3D culture systems, although the effects were distinct for the two culture 
systems.  Constitutively-active Cdc42 caused MECs growing in monolayer culture to adopt traits 
similar to those observed in NIH 3T3 fibroblasts expressing this mutant, including actin-rich stress 
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fiber formation and multi-nucleated cells.  However, MECs expressing constitutively-active 
Cdc42 in 3D culture commonly caused a filling of the alveolar luminal space and cell invasion 
into the surrounding extracellular matrix, traits which are characteristic of ductal carcinoma in situ 
and invasive ductal carcinoma of the breast, respectively (12).  The invasion of MECs into the 
extracellular matrix began with the display of IQGAP1-rich invadopodia surrounding the laminin-
rich periphery of the alveoli, which over time resulted in a large degree of cellular migration away 
from the primary alveoli.  Normal ductal morphogenesis in this culture system involves a similar 
migration of cells through the 3D matrix (28), but results in the formation of a new alveolar bud 
composed of apical-basal polarized cells, with IQGAP1 localized to the cell-to-cell contacts 
(Figure 3.6).  In contrast, the Cdc42[F28L]-expressing MECs also expressed IQGAP1, but were 
unable to form new alveoli, suggesting that the effects of constitutively-active Cdc42 in primary 
MECs dominated the morphogenesis cues, resulting in a morphological phenotype distinct from 
that normally imparted by the 3D environment. 
 IQGAP1 has been shown to bind to β-catenin, with this interaction disrupting the binding 
of β-catenin to E-cadherin (29).  As the catenin family members also bind to the cytoskeleton, the 
interaction of β-catenin with E-cadherin ultimately results in the stabilization of E-cadherin-based 
cell junctions (30).  This connection of the cytoskeleton to adherens junctions allows for an 
interactive cytoskeletal network to form between multiple epithelial cells, a characteristic that is 
essential for the proper cellular organization and communication that needs to occur within tissues 
(31).  Considering this, constitutively-active Cdc42 may be serving two functions by down-
regulating the epithelial characteristics of MECs growing in 3D culture.  First, Cdc42[F28L] may 
be unable to adequately sequester IQGAP1 from β-catenin due to its rapid cycling between a 
signaling “on” (GTP-bound) and signaling “off” (GDP-bound) state, which over time may result 
110 
 
in an accumulation of IQGAP1-β-catenin complexes, and thus weakened adherens junctions.  
Secondly, Cdc42[F28L] binding to IQGAP1 may induce CLIP-170-mediated microtubule (+) end 
capture at the plasma membrane, allowing for the formation of leading edges as well as the 
transport of MMPs along the microtubules to those sites, thereby enabling invasive migration.  
 Along with the invasiveness exhibited by MECs expressing constitutively-active Cdc42, 
E-cadherin-based cell-cell contacts were disrupted in these MECs.  As Cdc42[F28L] induced the 
MECs to form IQGAP1-rich invadopodia that ultimately resulted in large cellular outgrowths into 
the surrounding stroma, these invasive MECs also began to down-regulate their expression of E-
cadherin.  The ability of Cdc42 to down-regulate E-cadherin expression has been observed 
previously, and is a direct result of the Cdc42-dependent potentiation of EGFR-signaling activity, 
resulting in higher levels of activated Src (32).  Active Src can phosphorylate E-cadherin molecules 
at the cell membrane, resulting in a higher potential for their ubiquitylation and lysosomal 
targeting.  This process can have a significant impact over time, as the steady-state recycling and 
sorting of E-cadherin molecules from the plasma membrane becomes shifted towards E-cadherin 
lysosomal degradation.  This mechanism may explain our observation of constitutively-active 
Cdc42 expression resulting in MECs that are invasive and fail to express high levels of E-cadherin.  
E-cadherin-based cell contacts are critical in the morphogenesis of many tissues and organs, and 
help to regulate the migration and invasion of epithelial cells (33).  Breast cancer cells must down-
regulate E-cadherin expression to continue their growth in the absence of appropriate growth factor 
signaling, so much so that E-cadherin expression has become a common therapeutic index for 
human breast cancer tumor grading and therapy selection (34, 35).  The ability of Cdc42[F28L] to 
disrupt E-cadherin cell-cell junctions and stimulate the growth of primary MECs in 3D culture, 
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promoting their transition to an invasive phenotype, highlights the importance of the signaling 
roles of Cdc42 during breast cancer progression.   
 The capability of constitutively-active Cdc42 to confer upon primary MECs an invasive 
phenotype relied on this mutant’s ability to bind the scaffolding protein IQGAP1.  Interestingly, 
the expression of Cdc42[F28L,F37A], a constitutively-active Cdc42 mutant that has been shown 
to be unable to bind IQGAP1, still induced the primary MECs to fill the alveolar luminal space 
but failed to stimulate the ability of MECs to invade out of their laminin-rich extracellular matrix.  
These results suggest that the interaction of Cdc42 and IQGAP1 can affect the transition that takes 
place as breast carcinomas advance from DCIS, which display luminal filling but not invasion into 
the surrounding tissue, to invasive ductal carcinomas that are not only neoplastic but also invade 
into their stroma.  Intervention of Cdc42-IQGAP1 signaling may represent a potential therapeutic 
strategy to prevent the progression of breast tumors to metastasize to other sites within the patient.   
 Here, I have taken a two-pronged approach using primary cell culture systems to address 
the roles of a constitutively-active Cdc42 mutant in MECs.  While Cdc42[F28L] caused primary 
MECs to display stress fiber formation and multi-nucleation in monolayer growth, I found that 
constitutively-active Cdc42 also had significant effects on MECs grown in 3D culture.  
Considering the wealth of knowledge regarding Cdc42 signaling across multiple model systems, 
this context-dependent perspective of Cdc42 provides further insight into the relationship of the 
Cdc42 signaling found in normal-functioning mammary epithelial cells as compared to neoplastic 
and invasive ductal carcinomas.  As epithelial cells within the mammary gland begin to lose the 
appropriate response to their extracellular environment, they exhibit aberrant cellular growth as 
they progress toward a transformed phenotype (36).  Combining the previously-identified roles for 
Cdc42 in cell-cycle control (37), cell metabolism (38) and migration (39), with the results obtained 
112 
 
in this study, suggests that a complex array of signaling outputs emanate from Cdc42 in epithelial 
cells within human tissues.  Understanding this complexity from a therapeutic perspective may 
require the integration of multiple model systems to observe how cells orchestrate their use of 
Cdc42 to achieve a variety of physiological functions, and how this changes in diseases such as 
breast cancer.  
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Chapter 4 
 
Conclusions and Perspectives 
 
 Due to the wide array of cellular outputs to which they can contribute, small GTPases have 
gained considerable attention in both developmental and disease studies during recent decades. 
During this time, Cdc42 has become a central signaling molecule in the regulation of a variety of 
cellular processes such as migration, division, differentiation and metabolism (1–6), drawing focus 
to the importance of the regulatory mechanisms evolved by human cells to use Cdc42 signaling 
for such a diverse variety of cellular activities and biological outcomes.  As these types of cellular 
processes can lead to disease when not properly regulated, a better understanding of the 
mechanisms by which cells control and utilize Cdc42 signaling can contribute toward developing 
effective therapies. 
  The research presented in this thesis was centered on examining the roles of Cdc42 during 
normal mammary gland development, with the hope of ultimately applying that knowledge toward 
understanding how it might influence breast cancer progression.  The initial study, presented in 
Chapter 2, was designed to use a loss-of-function approach to identify which of the normal 
functions of adult mammary epithelial cells relied on Cdc42.  We found that the primary effect 
caused by Cdc42-deletion in the adult mouse mammary gland was a disorganization of the 
epithelial compartment, due to a loss of both apical-basal cell polarity and E-cadherin-based cell-
cell junctions.  These changes caused by the deletion of Cdc42 led to premature epithelial cell 
sloughing (Figure 2.7), which in turn affected the gene expression profile within the mammary 
gland, as evidenced by RNA sequencing analysis in Chapter 2.   
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Comparing this Cdc42 conditional knockout mouse phenotype with those from studies 
deleting Cdc42 in other tissues of the mouse brings to light a common thread in Cdc42 functioning 
in vivo, which is the maintenance of cell polarity and cell-cell communication.  The loss of proper 
cell polarity and cell-cell communication found in different mouse tissues with targeted Cdc42-
deletion led to intriguing changes in overall tissue form and function.  When Cdc42 was deleted 
in the pancreas of mice, an organ that requires tubulogenesis comparable to that found within the 
mammary gland, proper lumen formation was interrupted.  Interestingly, when Cdc42 was deleted 
in this model system, the loss of proper lumen formation was accompanied by a shift in cell fate, 
resulting in higher levels of acinar cell differentiation and lower levels of ductal cell differentiation 
(7).  A change in cell fate was also observed in mice where Cdc42 was either deleted in the nervous 
system or the skin, resulting in altered oligodendrocyte and hair follicle differentiation, 
respectively (8, 9).  Altogether, these findings highlight important roles for Cdc42 in orchestrating 
the coordination of signaling outputs in mammalian cells, such that they are able to attain proper 
cell fate and form functional tissues.   
Conditional-deletion mouse models have provided valuable insight toward the 
understanding of the in vivo roles of Cdc42 in various tissues, and in doing so have raised further 
interest concerning the roles Cdc42 may have in a disease such as cancer, where proper apical-
basal cell polarity and cell-cell communication are commonly lost.  As Cdc42 is found to be 
overexpressed in certain ductal carcinomas of the breast (10), I next wanted to analyze the effects 
of its aberrant signaling in mammary epithelial cells to determine how the roles identified for 
Cdc42 in Chapter 2 may be altered.  To accomplish this, I utilized the constitutively-active 
Cdc42[F28L] mutant, which through its hyperactive downstream signaling has been shown to 
confer cancer-like characteristics onto fibroblasts (11).  As in vivo studies have suggested that, by 
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influencing cell polarity and cell-cell communication, Cdc42 signaling can affect the overall 
interactions of epithelial cells with their tissue environment, I wanted to examine the effects of 
hyperactive Cdc42 signaling using a model system that provides epithelial cells with an 
environment similar to that found in their native tissue.  To this end, I cultured primary mammary 
epithelial cells (MECs) in not only monolayer but also 3-dimensional (3D) conditions.   
When examined using a monolayer culture system, Cdc42[F28L] caused a phenotype in 
primary MECs resembling that observed in NIH 3T3 fibroblasts (11), with actin-based stress fiber 
formation and multi-nucleated cells (Figure 3.4).  These data suggest that the actions of 
hyperactive Cdc42 signaling are indeed similar between these cell types when analyzed in a 
monolayer growth model system, but also bring to question how the previously-identified roles for 
Cdc42 in vivo, such as the maintenance of proper epithelial cell-cell contacts, may be affected by 
aberrant Cdc42 signaling.   
To begin to address these types of questions, I cultured primary MECs within a 3D 
substratum, a condition that allowed the cells to undergo morphogenesis into hollowed luminal 
structures, a process that relies on cell-cell communication similarly to what is found in vivo.  
Using this model system, the expression of constitutively-active Cdc42[F28L] drove the primary 
MECs toward an invasive phenotype, but did so in an IQGAP1-dependent manner (Figures 3.5 
and 3.7).  The primary MECs expressing Cdc42[F28L] lost the normal localization of E-cadherin 
at cell-cell contacts (Figure 3.7), and no longer formed normal, hollowed alveolar lumens.  Instead, 
MECs expressing Cdc42[F28L] began to abnormally fill the luminal space and invade out into the 
surrounding environment.  These cellular characteristics are comparable to what is found in breast 
carcinoma development, where cancerous cells begin to fill the alveolar or ductal luminal space 
and, in the case of invasive ductal carcinoma, invade into the surrounding tissue and metastasize.  
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However, the hyperactive mutant Cdc42[F28L,F37A], which is constitutively active but unable to 
bind to IQGAP1, also caused a loss of proper lumen formation but did so without inducing invasive 
traits in the MECs.  These results showed that hyperactive Cdc42 signaling was capable both of 
altering the normal MEC functions associated with proper alveolar morphogenesis, and of causing 
the cells to invade into their surrounding environment.  As epithelial cell interactions with their 
extracellular environment can affect not only cell invasion, but also cell polarity, proliferation and 
differentiation, they have become highly relevant to the study of breast cancer (12, 13), further 
signifying the phenotype caused by Cdc42[F28L] in primary MECs.   
Combining our results with those from other studies indicates that Cdc42 serves as an 
integral regulator in progenitor and epithelial cell sensing of the tissue environment (7, 14–16), a 
process that has a significant effect on the overall differentiation status of epithelial cells (17).  
Epithelial cells rely on extracellular cues such as E-cadherin-based contacts to maintain their form 
and function in tissues, whereas in cancer cells, sensing of such extracellular cues becomes altered 
to allow for abnormal growth and survival.  An intriguing therapeutic approach might be to develop 
strategies that cause cancer cells to regain proper responsiveness to their native tissue environment, 
with the goal of inhibiting abnormal cell growth and inducing programmed cell death.  To this end, 
studies using the ectopic expression of genes such as E-cadherin in cancer cells have shown 
effective inhibition of cell proliferation and tumor progression (18, 19).  In Chapter 2, we show 
that the deletion of Cdc42 lowers the expression level of E-cadherin and shifts its localization 
within mammary epithelial cells, from cell-cell membrane contacts to a cytosolic distribution 
(Figure 2.5).  The differentiation status of the Cdc42-null MECs also appeared to be affected, as 
they did not undergo the normal programmed cell death which is associated with mammary 
epithelial sloughing (Figure 2.7), but displayed the abnormal expression of Cytokeratin 8 and N-
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cadherin (Figure 2.5), both of which are associated with cancerous growth within the breast (20, 
21).  In Chapter 3, the expression of constitutively-active Cdc42 in primary MECs also affected 
E-cadherin localization and expression (Figure 3.7), and this was accompanied by a shift of the 
cells toward an invasive phenotype.  Together, these two studies link Cdc42 to the control of 
mammary epithelial cell function and fate.  Future studies using the 3D culture of primary MECs 
will be required to address how altering Cdc42 signaling leads to these interesting cellular changes. 
The Cdc42 effector that may be the link between the phenotypes observed in the mouse 
mammary gland (Chapter 2) and the primary MEC culture models (Chapter 3) is IQGAP1.  This 
scaffolding molecule has been shown to have a significant effect on the stability of E-cadherin at 
epithelial cell-cell junctions (22), possibly explaining why the deletion of Cdc42 in the mouse 
mammary gland resulted in altered E-cadherin localization and expression (14).  In the 3D culture 
of primary MECs, the ability of Cdc42[F28L] to cause invasiveness was also linked to IQGAP1 
signaling, which might be related to the previously-identified role for Cdc42 and IQGAP1 in 
recruiting microtubule (+) ends to the leading edge of migrating cells (23).  This type of 
coordination of microtubules can facilitate the transport of matrix metalloproteinases to the cell 
membrane, where they are capable of breaking down extracellular basement membrane proteins 
to allow for the type of cell invasion associated with cancer metastasis (24).  Similarly to Cdc42, 
IQGAP1 has been shown to affect a wide array of cellular functions, including proliferation, 
differentiation and migration (25), and changes in its expression or function are related to cancer 
progression.  The research presented in this thesis suggests a reliance of mammary epithelial cells 
on the proper regulation of Cdc42 and IQGAP1 functioning and, in the case of aberrant Cdc42 
signaling, the actions of these molecules can propel MECs to lose their normal alveolar structures 
and invade into their surroundings.  In efforts to understand the progression of breast tumors, 
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cancer cell metastasis has been extensively investigated, as it represents a critical stage of tumor 
progression that affects the prognosis and ultimate survival of breast cancer patients.  As such, 
many studies have targeted the acquisition of invasive mobility within cancer cells (26), with the 
goal of inhibiting the dissemination of the primary tumor cells from the mammary parenchyma to 
the rest of the patient’s tissues.  Because of this, the functional consequences of the interaction 
between Cdc42 and IQGAP1 require further examination using in vivo and primary MEC culture 
models.  Of particular interest would be evaluating the functional significance of the interaction 
between Cdc42 and IQGAP1 during in vivo tumorigenesis, to determine whether aberrant Cdc42 
signaling can drive breast tumor formation along with metastasis in an IQGAP1-dependent 
manner.   
In conclusion, the research presented in this thesis has contributed in part to the vast 
knowledge base concerning Cdc42 signaling during both normal development and cancer 
progression, yet questions still remain concerning how human epithelia have evolved such 
exquisite control over the use of this small GTPase.  While the expression level, activity-state and 
localization of Cdc42 can together begin to describe how cells can use one gene to perform such a 
variety of functions, the complexity of the cell signaling found to be emanating from Cdc42 will 
require further research using multiple model systems.  The use of several complementary model 
systems was essential to the progression of this research, and further integration of the data 
generated from these multiple model systems appears to be the next essential step in establishing 
a physiologically-relevant view of Cdc42 signaling in the mammary gland.  As E. O. Wilson stated, 
“We are drowning in information, while starving for wisdom.  The world henceforth will be run 
by synthesizers, people able to put together the right information at the right time, think critically 
about it, and make important choices wisely.” 
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